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Abstract  
 
Previous research has suggested that looking at a painful body part has an analgesic 
effect on experimental pain. Furthermore, it has been demonstrated that magnifying 
the size of the viewed part has a greater analgesic effect, while minifying the 
perceived size of the body part reduces the analgesia. These studies involved the 
application of a noxious stimulus to the skin, inducing pain that is perceived 
superficially. It is believed that most clinical pain is likely contributed to by noxious 
information from deep tissues and is certainly more commonly perceived as deep 
(below the skin surface). Research on clinical populations has also supported the idea 
that visualisation of the painful body part is analgesic, however the effects of 
magnification and minification are opposite to those seen with an experimental pain 
paradigm. While a number of mechanisms might explain these differences it is 
possible that the modulatory effect of vision is different for pain that is perceived 
superficially to that which is perceived deeply. 
Here we explore the effects of visualisation and visual enlargement on experimental 
deep tissue pain of the anterior thigh. All participants undertook a bout of high load 
eccentric exercise to induce delayed onset muscle soreness.  Twenty four hours later 
those participants who reported at least a moderate level of muscle soreness were 
tested in a four phase randomised cross-over experiment.  We measured pain 
intensity during the performance of a standardised quadriceps contraction under 
four different visual conditions, namely: normal visualisation of the thigh; magnified 
visualisation of the thigh; visualisation of the contralateral uninjured thigh and 
visualisation of a neutral object. Contrary to previous research on superficially 
perceived pain, we found no difference in pain intensity across any of the four 
conditions. These results demonstrate that visualisation does not have an analgesic 
effect on experimental deep tissue pain, suggesting that different modulatory factors 
exist for superficial and deep experimental pain.  It also proposes the notion that 
visualisation may only have a modulatory effect on experimental pain when visual 
feedback offers a significant contribution to the perception of safety of the 
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stimulated structure. Visualisation provides clear information that all is well with the 
skin but less credible evidence that all is well with deep structures, however this 
hypothesis remains to be tested. 
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CHAPTER ONE: INTRODUCTION 
 
1.1  Topic and Purpose 
Chronic pain has a debilitating impact not just on the lives of the sufferers, but also 
on the broader Australian community. It is one of Australia’s most widespread health 
issues, costing the economy over $34.3 billion annually (MBFFoundation, 2007).  In 
2003, the medical cost of managing lower back pain alone in Australia was $A 1.02 
billion, which was relatively insignificant compared to the societal cost of $A 8.5 
billion (Walker, Muller, & Grant, 2003). Chronic pain affects almost one in three 
Australians (Blyth et al., 2001) and is often accompanied by mental disorders such as 
depression, anxiety and suicide attempts (Twillman, 2007). Although our 
understanding of pain is constantly evolving and improving, much remains unknown 
regarding pain mechanisms, particularly the host of factors which interact to 
modulate the perceived pain experience. As a result the effects of most common 
treatments are modest and the burden of pain continues to escalate. 
To date, several experiments have investigated the modulatory effect of visualisation 
on pain using a paradigm of delivering noxious stimulation to the skin (Diers et al., 
2013; Longo, Betti, Aglioti, & Haggard, 2009; Mancini, Longo, Kammers, & Haggard, 
2011; Osumi et al., 2014) . These studies have helped to indicate the potential 
analgesic effect of visualisation and to suggest strategies that might be useful in the 
management of clinical pain (Diers, Loffler, Zieglgansberger, & Trojan, 2015; Wand et 
al., 2012). However, there are a number of important differences between pain 
arising from experimental stimulation of the skin and clinical pain.  One distinction is 
that it is thought that noxious information arising from deep tissues make a more 
significant contribution to the emergent pain experience than noxious information 
from the skin (Bove, Zaheen, & Bajwa, 2005).  One important step in determining if 
visualisation evoked analgesia might be a useful clinical tool is to investigate if the 
phenomenon holds true for pain evoked from noxious deep tissue stimulation.     
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This study is novel in that it will explore experimental pain mediated by input from 
deep tissues, in particular to see whether factors which have been shown to have 
modulatory effects on pain evoked by superficial tissue stimulation influence pain 
evoked by deep tissue stimulation in the same way. Firstly, it will investigate whether 
visualisation of the painful body part affects the perceived intensity of pain. Secondly, 
it will attempt to establish whether visual magnification of the body part has any 
further effect on the perceived pain level, as has been demonstrated in superficial 
experimental pain.  
The primary purpose of this study is to establish whether vision and visual 
magnification modulate pain perception and in so doing to better understand the 
mechanisms modulating pain perception when deep tissues are nociceptively 
activated, as these may assist our approaches to management of clinical pain states.  
 
  
 3 
 
1.2  Background 
Traditionally the experience of pain was believed to be synonymous with nociception. 
Pain was regarded as a linear sensory experience dependant only on A  Delta and C 
nociceptive fibres transmitting impulses to a “pain” centre in the brain (Melzack, 
1996), that is pain was thought to reside within the peripheral tissues and blocking 
nociception was seen as the fundamental therapeutic approach. Over the last four 
decades our understanding of pain has been revolutionised, with nociception now 
seen as only one component of the emergent pain experience. Indeed it is now clear 
than nociception is neither necessary nor sufficient for the production of pain. Pain 
does not exist within the tissues but is created by the brain (Moseley, 2007).  
Pain emerges into consciousness when the brain decides that the body’s tissues are 
under threat and action is required (Moseley & Flor, 2012). This involves the 
processing, scrutinising and modulation of multiple information sources at a number 
of levels throughout the neuraxis (Moseley, 2007) and importantly emphasises that 
the management of pain has multiple targets. Essentially, anything that decreases 
the individual’s perception of danger to the tissues has the potential to moderate the 
pain experience. The multi-sensory emergent nature of pain is highlighted by recent 
work demonstrating the importance of visual input on modulating the pain 
experience.  
Longo et al. (2009) showed in healthy volunteers that observation of the body part 
while an unseen painful stimulus is applied topically to that body part has an analgesic 
effect  compared to observation of a neutral object. They adopted the term “non-
informative analgesia” as the stimulus is not visualised, ruling out the opportunity of 
attributing the analgesic effect to the observation of the agent responsible for 
noxious stimulation. Similar results were observed by Diers et al. (2013) in a chronic 
back pain population. Visual feedback of the patients’ own backs reduced the 
perceived intensity of experimentally induced pain. Diers et al. (2015) expanded the 
concept of visual analgesia by observing it in a chronic back pain population, in this 
case demonstrating that the intensity and unpleasantness of the subjects’ habitual 
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perceived back pain could be reduced by subjects watching their back on a video 
screen. 
However, the effect of visualisation on perceived pain is not yet beyond doubt. 
Subsequent to the design of our study, research with contrasting results has 
emerged. Valentini, Koch, and Aglioti (2015) recorded an analgesic effect only when 
viewing the hand was combined with the hand crossing the midline. No analgesia was 
experienced with visualisation alone. Torta, Legrain, and Mouraux (2015) did not 
observe visual analgesia at all either when subjects viewed a mirror image of their 
hand or when they viewed their hand directly. Clearly more work is needed to explore 
the effect of visualisation on pain intensity.   
The effects of visual distortion of body size on pain perception have also been 
explored. Mancini et al. (2011) proposed a dose-response relationship to visual 
analgesia. With magnification of the perceived size of the body part an increased 
analgesic effect was observed whereas minification of the body part reduced the 
analgesic effect.  
Subsequent to these findings Osumi et al. (2014) suggested that an analgesic effect 
to a magnified view of the body part is not necessarily a standard response. Exploring 
possible factors associated with modulation of pain by visual distortion of size, Osumi 
et al. (2014) used a mirror to reflect and augment the size of the viewed hand while 
applying a topical noxious heat stimulus to the unviewed hand. Subjects who 
exhibited a higher pain threshold under the enlarged hand condition were also found 
to experience more vivid somatosensory perception and reported that they felt 
“nothing special” in response to the view of the enlarged limb. The subjects who 
demonstrated a lower pain threshold under the enlarged condition did not show any 
significant difference in two-point discrimination and responded that they felt 
unpleasant emotions towards the view of the enlarged hand. This study suggests that 
specific factors are associated with modulation by visualisation and visual distortion 
of size. Their study introduces some of these factors however investigation to explore 
further conditions for an effect by visualisation is warranted.  
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In contrast to the positive effects of magnification observed by Mancini et al. (2011), 
Moseley, Parsons, and Spence (2008) demonstrated an augmented pain response to 
a magnified view of the upper limb in the case of chronic regional pain syndrome 
(CRPS) patients and an analgesic response to the minified view of the limb. 
Ramachandran, Brang, and McGeoch (2009) found a similar analgesic response to 
minification of the reflection of the intact limb (which was perceived as the phantom 
limb) in a patient with phantom limb pain.    
The studies by Longo et al. (2009),  Mancini et al. (2011), Diers et al. (2013) and Osumi 
et al. (2014)  involved the application of noxious stimuli to the skin of subjects. We 
still know relatively little about modulatory factors influencing clinical pain states and 
whether the findings of studies involving experimental topical noxious stimuli can be 
extrapolated to the clinical environment. There are a number of important 
differences between pain arising from noxious stimuli applied to the skin and pain 
arising from noxious stimuli from deeper tissues. One distinction is that it is thought 
that noxious information arising from deep tissues make a more significant 
contribution to the emergent pain experience in clinical pain states than noxious 
information from the skin (Bove et al., 2005).  An important step in determining if 
visual analgesia might be a useful clinical tool is to investigate if the phenomenon 
holds true for pain evoked from experimental deep tissue stimulation. A better 
understanding of deep tissue pain could potentially assist us to target treatment of 
chronic pain conditions more appropriately.  
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1.3  Development of this Research Study 
In the previously-mentioned experimental studies, pain has been induced through 
topically applied noxious input. The resultant superficially felt pain is potentially very 
different to clinical pain for a number of reasons, one of which is that clinical pain is 
thought to be more commonly associated with noxious input from deeper structures. 
This study was developed with a view to generate deep tissue pain in normal subjects’ 
quadriceps muscles by inducing delayed onset muscle soreness (DOMS), and then to 
investigate the effects of visualisation and visual distortion of size, in the form of 
magnification, on pain perception. An experimental healthy population was used in 
order to minimise extraneous influences that clinical states introduce.   
Many of the experimental studies which have demonstrated the existence of visual 
analgesia and analgesic responses to visual distortion of body size have made use of 
mirror boxes to allow for “non-informative” noxious stimulation (Longo et al., 2009) 
and for manipulation of perceived size of the limb.  It has recently been suggested 
that use of the mirror box may induce an analgesic effect rather than the visualisation 
component of these experiments per se. The proposed mechanism underlying this 
mirror-box analgesia may involve a degree of conflict (introduced by the mirror) 
between a subject’s proprioceptive, somatosensory and visual representations  
(Torta et al., 2015), the added attentional processes that embodiment of the 
reflected image might entail or simply the greater novelty of viewing a reflected 
image. In light of this possibility, we used magnifying glasses to visually distort the 
view of the limb rather than concave and convex mirrors positioned on a mirror-box. 
This excluded the possibility of the reflected image contributing to “visual analgesia”. 
Given the ambiguity of previous findings and the lack of visualisation-analgesia 
studies in deep tissue our hypotheses were: 
1. Visualisation of the painful body part will have an effect on deep tissue pain 
2. Pain perception will be modified by visual distortion of the size of the viewed 
quadriceps muscle, in the form of magnification. 
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As part of our study we included the use of the short version of the Pain Anxiety 
Symptom Scale (PASS-20) (Appendix 1) and the Pain Sensitivity Questionnaire (PSQ) 
(Appendix 2). These have both been shown to be reliable predictors for the 
development of chronic pain (Lance M. McCracken & Dhingra, 2002; Ruscheweyh, 
Marziniak, Stumpenhorst, Reinholz, & Knecht, 2009). The researchers felt it would be 
worthwhile to explore for any interaction between pain anxiety, trait sensitivity and 
pain during the various visual conditions. Modifying the subjects’ view of their thigh, 
particularly in the case where the view of the thigh was obstructed by a neutral 
object, had the potential to affect their anxiety levels and this in turn could have had 
some impact on their perceived pain levels. 
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1.4  Potential Significance  
Recent research results indicate that visualisation can potentially modulate pain 
perception and furthermore visual distortion of body size can further modify the pain 
experience. However, the direction of the effect is at this stage disputed, as 
contrasting findings have been observed both within experimental conditions 
involving superficial pain and in clinical populations. This study attempted to establish 
whether visualisation of the painful body part has an effect on experimental deep 
tissue pain, and if so, whether this was in the direction of analgesia.  Secondly, this 
study explored whether visual distortion of body size impacts pain perception, 
specifically magnification of the viewed body part. Exploration of deep tissue pain is 
necessary as most clinical pain is believed to involve noxious input from tissues 
deeper than the skin. The results of this study could form the basis for future therapy 
targeting chronic deep tissue pain; that of manipulating multisensory input (such as 
vision) to modulate the pain experience.  
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CHAPTER TWO: LITERATURE REVIEW 
 
 
2.1  Past Concepts of Pain 
Until the 1960’s, pain was believed to be a specific sensory modality, comprising 
peripheral receptors and unique, afferent neural pathways, terminating in a distinct 
centre in the brain. It was paralleled to modalities such as vision or hearing. 
Nociceptors were thought to detect noxious stimuli in the periphery and convey 
impulses, to the “pain centre” in the brain. The intensity of perceived pain was 
thought to reflect only the extent of tissue damage in the periphery (Melzack, 1996) 
and the blocking of nociception was seen as the primary therapeutic approach. 
In 1965 Melzack and Wall started to question the traditional linear concept of pain as 
it did not explain complex pain phenomena such as causalgia. They presented the 
Gate Control Theory, a theory that small fibre nociceptive pathways responsible for 
signalling pain (C fibres) were inhibited by concomitant large fibre inputs signalling 
touch or other modalities (Aβ). Nociception was believed to be modulated 
peripherally at a spinal level, before ascending to evoke the perception of pain 
(Melzack, 1996). This was one of the first concepts proposing modulation of pain, and 
led to further investigation of this phenomenon. 
Over the past four decades, our concepts of mechanisms underlying pain have 
evolved radically to the point where we now believe pain to be a complex interaction 
of multiple inputs creating a subjective, multidimensional, emergent experience 
(Grieve & Schultewolter, 2014). This complex perception is reflected in the current 
definition of pain provided by the International Association for the Study of Pain 
(IASP): “An unpleasant sensory and emotional experience associated with actual or 
potential tissue damage, or described in terms of such damage” (Merskey & Bogduk, 
2012). 
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2.2  The Neuroanatomical Pathways of Nociception 
2.2.1 Peripheral nociception. 
Peripheral sensory nerves are responsible for conveying afferent signals to the spinal 
cord and ultimately the brain thus allowing for a conscious perception of the 
peripheral event that is taking place (van Griensven, 2005). Receptors transduce 
stimuli allowing transmission of a signal along the afferent fibre. These receptors can 
be specialized responding only to a specific stimulus, or they can be polymodal 
responding to various types of stimuli. Mechanoreceptos are sensitive only to 
mechanical stimulation such as pressure, touch, vibration etc. Chemoreceptors will 
only be activated by particular chemicals, and thermoreceptors will only be 
stimulated by changes in temperature. 
In mammals, most discriminative light touch sensation is mediated by the Aβ low-
threshold mechanoreceptors. Specialized Aβ low-threshold mechanosensory 
receptor end organs are classified into several different subtypes based on their 
structure. These include Meissner’s corpuscles, Pacinian corpuscles, lanceolate 
endings and Ruffini corpuscles (Fleming & Luo, 2013).  
Meissner’s corpuscles have an extremely low threshold for activation, responding to 
an indentation of the skin of less than 10µm. Meissner’s corpuscles have relatively 
small receptive fields and are most sensitive to low intensity stimuli (Fleming & Luo, 
2013). They are therefore sensitive to light touch, and although they can be found all 
over the skin, they are concentrated in sensitive regions such as the finger tips and 
lips. Pacinian corpuscles sense vibration and the fine texture of objects, while the Aβ 
low-threshold mechanoreceptors innervating hair follicles are lanceolate endings. 
Ruffini corpuscles act as stretch receptors, and appear to work with other 
proprioceptors to sense the position of the fingers and hands. 
Thermosensation is another sensory modality of the skin. Besides contributing to the 
temperature perception of an external stimulus it also contributes to the 
identification of an object through touch, by providing information about the 
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temperature of that object. Thermosensation is an important mechanism which 
contributes to the maintenance of a homeostatic condition in the body and it 
provides a protective function by detecting noxious hot or cold stimuli. Cutaneous 
thermosensation is mediated by a variety of primary afferent nerve fibres that 
transduce, encode and transmit thermal information. Specialized thermoreceptors 
are embedded in the free nerve endings of afferent fibres. Six “families” of 
thermoreceptors, known as transient receptor potential (TRP) ion channels, have 
been identified, whose activity depends on the temperature of the environment. 
Each of these receptor types is only activated over a particular range of temperatures, 
but together the receptors detect a full range of temperatures from noxious cold to 
noxious heat. Some of the thermoreceptors are specific to temperature only, while 
some of the thermoreceptors detect mechanical and chemical changes too, making 
them polymodal receptors (Schepers & Ringkamp, 2009). 
Nociceptors are sensory receptors that detect noxious stimuli. They can be highly 
specialized responding only to injury and inflammation, but they can also be relatively 
unspecialized, known as “polymodal”, responding to extreme and potentially 
damaging mechanical, thermal and chemical stimuli. Despite each neural afferent 
having specialized receptors, once all these receptors are activated, the process of 
converting a specific stimulus into an electrical signal and conducting it along the 
length of the nerve to the specific synapses at the dorsal horn, is identical (van 
Griensven, 2005).  
In a resting state, a voltage difference or “potential” exists across the membranes of 
nerve axons, creating an overall positive external environment compared with the 
negative interior. This is generated by active “ion pumps” in the membranes 
separating the positive sodium and potassium ions from the negative chloride ions. 
Ion channels in the cell membranes can be opened by mechanical force (in the case 
of mechanoreceptors), by specific chemicals known as ligands (in the case of 
chemoreceptors and thermoreceptors), or by direct depolarisation via an externally 
applied electrical charge. When these ion gates open, there is a rush of negative 
electrons through the gates as a result of the voltage across the membrane changing 
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the electrical charge of the nerve locally. Once this charge reaches its threshold, an 
action potential is created which results in the adjacent ion gates opening and the 
same cycle of depolarisation beginning there. This continues along the axon 
membrane allowing an electrical impulse to be carried along the nerve to its synapse. 
This process reflects the notion that impulses are generated in an ‘all-or-nothing’ 
fashion; the stimulus has to be sufficiently intense (noxious) to initially open the ion 
channels which will then propagate its own electrical impulse. Once depolarised, the 
membrane is restored to its normal resting state by the ion pumps. The stronger the 
stimulus, the more frequently action potentials will be generated, a process referred 
to as rate encoding. This entire process of converting a specific stimulus into an 
electrical impulse is known as transduction, whilst the impulse travelling along the 
nerve is referred to as transmission (van Griensven, 2005). 
This transmission of information via electrical impulses from the peripheral tissues to 
the central nervous system results in a conscious perception of events occurring in 
the peripheral tissue. Two types of afferent fibres exist for transmitting nociceptive 
signals; unmyelinated C fibres and myelinated A Delta fibres. Both are relatively thin 
which means they conduct signals more slowly than other sensory afferents, but 
because of the presence of the myelin sheath, the A  Delta fibres convey the impulses 
faster than the C fibres. This myelin sheath originates from the Schwann cells in the 
peripheral nervous system and the oligodendroglial cells in the central nervous 
system. The myelin insulates the axon, however it is not continuous along the entire 
length of the axon. There are spaces between the cells, termed Nodes of Ranvier, 
where the axon membrane is left exposed. These nodes are critical to the conduction 
of the impulse along the axon because the membrane underlying the myelin cannot 
undergo depolarisation and so this can only occur at the Nodes of Ranvier. The 
impulse therefore hops along the axon from node to node and is termed saltatory 
conduction. This conduction occurs at a much faster rate than the conduction of an 
impulse along an unmyelinated membrane via depolarisation of each adjacent 
segment of the membrane. Transmission along an A  Delta fibre occurs at 4-36m/s, 
while that along C fibres occurs between 0.4-3m/s (van Griensven, 2005). 
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The receptors at the terminals of the afferents are specific to the fibre type. 
Polymodal receptors, which are stimulated by chemical, thermal or mechanical 
stimuli, are generally associated with C fibre types. Mechanical nociception tends to 
be transmitted by A Delta fibres while thermal nociception is subserved by both A 
Delta and C fibres. As a result of the different conduction speeds, receptor field sizes 
and the speed of accommodation of these two fibre types, we are able to perceive 
different qualities in the nature of one noxious stimulus. The A Delta fibres tend to 
give rise to the perception of a short-lived, sharp pain while the C fibres generally 
evoke a more diffuse aching or burning with longer-lasting effects.  (van Griensven, 
2005).  
Once a nociceptive afferent has been sufficiently stimulated to trigger an action 
potential, stored neuropeptides in the peripheral terminals of the neuron, such as 
substance P and Calcitonin Gene Related Peptide (CGRP), are released into the local 
tissues from whence the stimulus arose. This has the effect of causing vasodilation of 
the local capillaries and stimulation of mast cells to release histamine. Together, 
these effects result in an increased collection of interstitial fluid as the plasma leaks 
from the permeable blood vessels. The histamine also has a sensitising effect on the 
nerve endings in the area by lowering the membrane potential, facilitating 
depolarisation and generation of action potentials. Besides the neuropeptide being 
released when a nociceptor is activated, antidromic impulses are also generated. 
Most of the impulses travel proximally along the fibre tract towards the spinal cord, 
but antidromic impulses are those that stray from the general direction of the 
current, to flow down branches of the same fibre tract toward other peripheral 
terminals. When these impulses arrive at the terminals further neuropeptides are 
released in this vicinity which will in turn have a vasodilatory effect and cause 
increased amounts of histamine to be released from mast cells into this new area. 
This in turn, increases local inflammation. The area may appear red and the increase 
in blood flow to the area increases the local temperature. Swelling results from 
oedema in the extravascular space and this can further induce pain due to the 
stretching and distortion of the tissue. 
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2.2.2 Spinal cord. 
The dorsal horn of the spinal cord is the ultimate target and relay station for the 
primary nociceptive afferents and the impulse conveyed by them. The dorsal horn is 
comprised of six distinct layers according to the specific modalities that the afferent 
neurons, which terminate there, convey. Despite the distinct laminae, there are 
branched collateral connections between lamina layers which are likely to allow for 
‘cross-talk’ between nociceptive and non-nociceptive afferents at this level. It is 
thought these potential connections may play a role in pain modulation (Basbaum & 
Jessel, 2000). 
Second order neurons in lamina I (marginal layer) are primarily nociceptive specific 
neurons that respond only to noxious and thermal stimuli, receiving input from 
afferent A Delta and C fibres, which synapse directly with them in the dorsal horn. 
These are known as nociceptive-specific neurones (NS neurones). Some of the 
neurones respond to a variety of stimuli and are known as wide-dynamic range 
neurones. Lamina V contains wide-dynamic range neurones which ascend to the 
brain stem and the thalamus. A β and A Delta fibres synapse in lamina V, so the 
neurons are activated by both noxious and non-noxious stimuli in this lamina. The 
neurons in this lamina have dendrites which extend into lamina I and are activated 
by the afferent C fibres which terminate in lamina I. It is within lamina V that the 
visceral and somatic nociceptors converge which could potentially explain the 
phenomenon of referred pain (Basbaum & Jessel, 2000). 
Lamina II (substantia gelatinosa) is made up of tightly-packed interneurons activated 
by noxious and non-noxious stimuli, having both an excitatory and an inhibitory 
function. The majority of neurons in lamina II receive information from sensory dorsal 
root ganglion cells as well as descending dorsolateral fasciculus (DLF) fibres. This 
lamina is believed to be important for the modulation of sensory/nociceptive input. 
Interneurones sensitive only to the Aβ neurones that synapse with them are 
concentrated in lamina III and IV and VI. They carry predominantly non-noxious 
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information and are arranged topographically according to the receptive fields of the 
afferent neurones. Some of the dendrites of lamina IV project to lamina II and 
possibly contribute to its modulatory function (Basbaum & Jessel, 2000). Lamina VII, 
found in the ventral horn, is polysynaptic and responds to noxious and non-noxious 
stimuli. It also receives input from both sides of the body, unlike the dorsal horn 
laminae, which may explain the diffuse nature of some pain conditions. 
Laminae I and V appear to be the laminae which play a direct role in the transmission 
of nociceptive signals up the spinal cord, while the other laminae potentially 
contribute to pain modulation, which occurs mainly in lamina II, via their cross-links 
with that lamina. Glutamate and substance P are the excitatory neurotransmitters 
released by the C and A  Delta fibres in the dorsal horn to facilitate the transmission 
(Basbaum & Jessel, 2000). 
The nociceptors synapse with spinal interneurons and the ascending fibres of the 
spinal cord in laminae I and V within the dorsal horn of the spinal cord. From here the 
ascending nociceptive signals are transmitted up the spinal cord to higher centres for 
processing through five tracts. 
The spinothalamic tract relays impulses to the thalamus. The axons cross the midline 
then ascend in the anterolateral white matter to the thalamus. The medial and lateral 
nuclei of the thalamus are primarily involved in nociception. Fibre tracts that project 
to the lateral nuclear group and the nuclear neurons, have small receptor fields and 
appear to play a role in the localisation of pain. The medial nuclei assist in processing 
nociceptive information and have projections which extend into the various cortical 
areas, such as the insular cortex, cingulate gyrus and the basal ganglia. The cingulate 
gyrus is part of the limbic system and is thought to be involved in the processing of 
the emotional component of a pain experience. The insular cortex contributes to the 
internal body response to the pain experience via the autonomic nervous system 
(Basbaum & Jessel, 2000). 
The spinoreticular tract relays information in the anterolateral white matter of the 
spinal cord to both the thalamus and the reticular formation, a neural network in the 
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brainstem which regulates the cardiovascular system, respiratory system and the 
sleep-wake cycle. The reticular formation is also responsible for posture, balance and 
motor function. In contrast to the spinothalamic tracts, these axons do not cross the 
midline. The spinomesencephalic tract axons run in the anterolateral quadrant and 
the dorsal part of the lateral funiculus, and is thought to contribute to the affective 
component of pain via its projections to the amygdala via the mesencephalic reticular 
formation and periaqueductal grey matter. The cervicothalamic tract fibres arise 
from the lateral white matter of the upper two cervical segments. They terminate in 
the cuneate and gracile nuclei of the medulla. These nuclei participate in the 
sensation of fine touch and proprioception. Finally, the spinohypothalamic tract 
projects to supraspinal autonomic control centres which regulate neuroendocrine 
and cardiovascular responses (Basbaum & Jessel, 2000). 
 
2.2.3 Brain structures involved in pain perception. 
Recent developments in structural and functional imaging methods have 
revolutionised neuroscience providing researchers with a better understanding of 
the organisation and behaviour of the brain. Structural imaging examines anatomical 
structure while functional imaging reveals physiological activity within particular 
tissues using tracers to reflect their spatial distribution within the body. 
Hemodynamic imaging methods rely on the fact that cerebral blood flow and 
neuronal activation are coupled. When an area of the brain is in use, blood flow to 
that region also increases. This method of imaging has allowed us to establish which 
areas of the brain are involved in pain perception. Electroencephalography (EEG) and 
magnetoencephalography (MEG) are other forms of functional imaging which are 
useful for demonstrating temporal sequencing and time delays in brain activation 
(Apkarian, Bushnell, Treede, & Zubieta, 2005). EEG is a monitoring method to record 
electrical activity in the brain, while MEG is a technique used to map brain activity by 
recording magnetic fields produced by electrical currents occurring with brain 
activity. 
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According to Basbaum and Jessel (2000) there are regions in the cerebral cortex 
which respond exclusively to nociceptive input. These authors believed these to be 
found in the somatosensory cortex, the cingulate gyrus and insular cortex. However 
a review by  Legrain, Iannetti, Plaghki, and Mouraux (2011) disputed this and 
proposed that the areas that were once thought of as nociceptive specific are better 
thought of as salient specific. Nociception is just one of many types of salient 
information that gives rise to a particular salient specific neurosignature. Event-
related brain potentials (ERPs) elicited in response to a salient stimulus involve three 
processes, namely the detection, localisation and reaction to a salient and potentially 
dangerous physical threat. These processes involve a wide range of sensory 
integration, such as visual and proprioceptive perception, not solely the processing 
of nociceptive input so the ERPs noted reflect this multisensory integration. Various 
brain centres have displayed ERPs in response to a salient noxious stimulus, hence 
contributing to the processing of nociceptive input and the ultimate perceived pain 
experience (Legrain et al., 2011). 
The primary somatosensory cortex (S1), secondary somatosensory cortex (S2) and 
the posterior portion of the insular cortex (IC) are commonly and concurrently 
activated following noxious stimulation, unlike that observed with tactile stimulation, 
where the IC and S2 are activated only after processing of the stimulus in S1. The S2 
and IC are therefore primary receiving regions for nociceptive input to the brain. 
These regions are thought to contribute to the sensory-discriminative functions of 
pain. The organisation within the S1 appears to follow the same somatotopy as 
observed for tactile input, however the evidence of this existing in S2 as well has not 
yet been established (Apkarian et al., 2005). 
As presented in the systematic review by Apkarian et al. (2005) one study 
demonstrated that visceral and cutaneous noxious input both led to activations in S1, 
S2, anterior cingulate cortex (ACC) and IC, but the exact area within the regions 
differed for the two types of pain. This suggests that there are potentially sub-regions 
within the brain structures responsible for processing noxious stimuli from different 
types of tissue. 
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The prefrontal cortex (PFC), is a heterogeneous brain area with the various gyri 
contributing to cognitive, emotional and memory function. The PFC, as well as 
parietal association areas, are involved in the cognitive components of pain 
perception such as memory or stimulus evaluation (Apkarian et al., 2005). 
While the posterior IC is involved in the sensory nature of pain perception, the 
anterior IC is part of the limbic system and is more closely linked anatomically and 
functionally to the PFC. and hence appears to contribute to the emotional, cognitive 
and memory related aspects of pain perception (Apkarian et al., 2005). The cingulate 
cortex, particularly the ACC is also a component of the limbic system, however it acts 
as an important interface between emotion and cognition, and is therefore involved 
in the cognitive-evaluative stages of pain processing. It is thought to be responsible 
for the affective-motivational component of pain (Apkarian et al., 2005). 
Subcortical activations, particularly in the thalamus, basal ganglia, and cerebellum, 
have also been observed during noxious stimulation, as well as activity in the motor 
and pre-motor cortical areas. It is thought that the motor and pre-motor cortices may 
be involved in pain-evoked movements, altered motor patterns or suppression of 
movement in the presence of perceived pain (Apkarian et al., 2005). 
Significant differences appear to exist between the parts of the brain involved in 
processing acute/experimental pain in normal subjects compared to the activation 
patterns seen in persistent clinical pain. Greater activation of the spinothalamic 
pathway, which transmits afferent nociceptive information through the thalamus to 
S1, S2, IC and ACC is observed with experimental pain induced in normal subjects, 
whereas with experimental pain induced in chronic clinical pain populations the 
proportion of activity in these primary sensory-evaluative areas is comparatively less, 
while the activation in the PFC is increased. As a result, it is postulated that the 
nociception transmission through the spinoparabrachial, spinohypothalamic and 
spinoreticular tracts is likely to increase. The emphasis shifting towards augmented 
PFC activity in the chronic pain conditions suggests a greater component of emotional 
and cognitive processing associated with the chronic pain state, and reduced sensory 
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processing. Thalamus activity is seen to increase temporarily as pain persists, but over 
time the activity actually diminishes. Decreased stimulus-related activity has been 
observed in this structure in chronic pain sufferers (Apkarian et al., 2005). A study 
using various brain imaging techniques confirmed a reduction in the anatomical size 
and function of the thalamus associated with chronic pain conditions, in particular, 
trigeminal neuralgia. This was proposed to impact on the thalamocortical circuitry 
resulting in persistent pain (Henderson et al., 2013).  
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2.3  Modulation of Pain 
Under normal circumstances it is generally assumed that our perception of pain is 
coupled with the amount of noxious information being received from peripheral 
tissue. However, pain is a complex phenomenon. Nociceptive input is modulated by 
various factors at various levels which can allow for the production of a very different 
pain experience which is not reflective of what is actually occurring at the tissue level, 
in fact nociception is neither sufficient nor necessary to produce the experience of 
pain (Butler & Moseley, 2013). Modulation appears to occur in the periphery at the 
nociceptor terminals, within the dorsal horn of the spinal cord, and in supraspinal 
centres.  
 
2.3.1 Peripheral modulation of pain. 
Peripheral nociceptors may be sensitised and even activated by certain stored 
chemicals released from the terminals and local tissue cells. This is known as 
peripheral sensitisation. Some of the substances that lower the threshold of 
nociceptors include histamine, which is released by damaged mast cells, and 
bradykinin, a chemical also released by damaged cells. These lower the threshold and 
bring about more regular depolarisation, and once this occurs nociceptors release 
stored neuropeptides, such as substance P which act directly on the local capillaries 
causing vasodilation, resulting in oedema. This process is termed neurogenic 
inflammation as it is induced by nociceptor stimulation.  Substance P is an excitatory 
neurotransmitter thought to be related to the transmission of pain information into 
the central nervous system at the dorsal horn. Substance P also sensitises the 
receptors in the periphery by causing undamaged mast cells to release more 
histamine. Reverse-flowing antidromic neural impulses also serve to further sensitise 
the local nociceptors and even those adjacent to injured areas, by resulting in the 
release of neuropeptides (Basbaum & Jessel, 2000). 
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The reduction in the threshold of these peripheral nociceptors underlies primary 
hyperalgesia, an increased pain experience to a noxious stimulus as a result of the 
increased sensitivity in the peripheral nociceptors (Woolf & Decosterd, 1999). 
 
2.3.2 Modulation of pain in the spinal cord. 
2.3.2i The dorsal horn. 
Modulation of pain also appears to occur within the spinal cord at the level of the 
dorsal horn. Inhibition of nociception occurs through the Gate Control mechanism, 
while facilitation of nociception occurs through the process of central sensitisation 
(Basbaum & Jessel, 2000). Furthermore, the descending pain modulatory system 
appears to be able to modulate pain in the dorsal horn in both an inhibitory or 
facilitatory direction as a result of activity in pain-related brain regions, linked to the 
dorsal horn by a network of neurons (Zusman, 2002). 
 
Central Sensitisation 
In response to nociceptor input dorsal horn neurons exhibit changes which can 
profoundly alter sensitivity by increasing membrane excitability, facilitating synaptic 
strength and even decreasing inhibitory influences in dorsal horn neurons 
(Latremoliere & Woolf, 2009). This state of temporary hyperexcitability can progress 
to a lasting state in the dorsal horn neurons. Together these processes are known as 
central sensitisation (Basbaum & Jessel, 2000). Central sensitisation comprises two 
distinct phases. 
 
The earlier stage of central sensitisation  
The first phase is the early phosphorylation-dependent and transcription-
independent phase. To induce central sensitization, C fibres terminals in somatic or 
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visceral tissue must undergo intense, repeated or sustained noxious stimulation 
(Latremoliere & Woolf, 2009). This results in rapid changes in glutamate receptor and 
ion channel properties (Latremoliere & Woolf, 2009). A fast augmentation of 
excitatory glutamatergic synapses in the superficial dorsal horn strengthens 
nociceptive transmission and recruits non-nociceptive input to the pathway. This is 
achieved by phosphorylation of numerous receptor and ion channel targets that lead 
to changes in threshold and an increase in the release of glutamate, substance P and 
CGRP. (Latremoliere & Woolf, 2009).This process is known as windup. It is perceived 
as an increase in pain intensity over time while a noxious stimulus is applied. Windup 
disappears within tens of seconds of the end of the stimulus train as the membrane 
potential returns to its normal resting level (Latremoliere & Woolf, 2009).  
Once phosphorylated in the process described above, protein kinase-C (PKC) 
decreases inhibitory transmission at the segmental level by reducing gamma amino-
butyric acid (GABA) inhibition and the descending inhibition driven from the 
periaqueductal grey matter (PAG). Disinhibition leaves dorsal horn neurons more 
susceptible to activation by excitatory inputs including non-nociceptive A-fibres. 
Elevation in intracellular calcium is also a major trigger of central sensitisation, 
activating multiple calcium-dependent kinases that act on receptors and ion channels 
to increase synaptic efficacy. Sustained release of glutamate by peripheral 
nociceptive activity and the neuropeptides substance P and CGRP leads to sufficient 
membrane depolarization to force magnesium ions (Mg2+) to leave the N-methyl-D-
aspartate receptor (NMDAR) pores, whereupon glutamate binding to the receptor 
generates an inward current of calcium ions (Ca2+) into the neuron. The increase in 
Ca2 concentration then activates numerous intracellular pathways, such as the 
extracellular signal-related kinase (ERK) that can contribute to the maintenance of 
central sensitization. Once activated, the ERK cascade results in changes in the 
threshold and activation kinetics of NMDA and α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA) receptors, boosting synaptic efficacy. A key feature 
of acute activity-dependent central sensitization is that it typically lasts for tens of 
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minutes to several hours in the absence of further nociceptor input (Latremoliere & 
Woolf, 2009). 
A peripheral stimulus is required initially to trigger central sensitisation, but once 
sensitized, noxious, non-noxious (e.g. A β stimulation) or even no stimulus can initiate 
an impulse in second order dorsal horn neurons. This is termed stimulus-generated 
pain hypersensitivity. The second-order neurones have a large number of 
“subliminal” connections with surrounding areas. Prior to sensitization a normal 
somatotopic map and sensory specificity is maintained, however following 
sensitization these connections start to respond more readily (Zusman, 2002).  
Clinically, this may present as hyperalgesia (known as secondary- or centrally-
mediated hyperalgesia), tactile allodynia, temporal summation, referred pain, 
hypersensitivity to thermal stimuli and even spontaneous pain at the stimulated site, 
but also at adjacent areas and even spreading to normal, more distant tissues 
(Basbaum & Jessel, 2000). Central sensitisation may also result in an increased 
duration of the painful experience, longer than would be expected from a particular 
stimulus.  
This increase in sensitivity noted in the early stage of central sensitization is 
protective, because it helps healing by limiting use of an injured body part until the 
injury is fully repaired (Latremoliere & Woolf, 2009). The hypersensitivity state is 
usually fully reversible, returning ultimately to its normal resting state, termed “basal 
sensitivity” (Woolf, 2011). It becomes pathological when central sensitization is 
maintained in the absence of active peripheral pathology (Latremoliere & Woolf, 
2009). 
 
The later stages of central sensitisation 
In cases of sustained noxious input or sustained high perceived threat, central 
sensitisation may persist. Different transcription-dependent changes are required for 
longer-lasting effects, and these generally do not occur in response only to brief 
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nociceptor activity but are the consequence of sustained input due to peripheral 
inflammation and nerve injury (Latremoliere & Woolf, 2009), though sustained 
descending excitatory input from higher centre may produce the same outcome (Bee 
& Dickenson, 2008). This later transcription-dependent phase drives synthesis of the 
new proteins responsible for the longer-lasting form of central sensitization observed 
in several pathological conditions. For example, ERK can lead to the activation of the 
transcription factor cAMP response element-binding protein (CREB) which drives 
expression of genes producing a long-lasting strengthening of the synapse 
(Latremoliere & Woolf, 2009). Also, as a result of peripheral inflammation the 
expression of centrally-acting neurotransmitters is increased, lowering the threshold 
allowing for more frequent or easily activated dorsal horn neuron depolarisation 
(Basbaum & Jessel, 2000). 
Central sensitization represents not only a state in which pain can be triggered by less 
intense inputs but in which the central sensitization itself can be maintained by a 
lower level or different kind of input. Ongoing activity in C-fibres, even at levels that 
do not initiate central sensitization in normal conditions, is sufficient to maintain 
central sensitization once it has been induced for prolonged periods (Latremoliere & 
Woolf, 2009).  
 
Gate Control 
This nociceptive-inhibitory phenomenon involves the activation the A β fibres. Non-
nociceptive A β (for perception of sensation) and nociceptive A Delta and C fibres 
converge onto common neurons in laminae I and V of the dorsal horn. Interneurons 
found in laminae I and II of the dorsal horn release inhibitory neurotransmitters, such 
as GABA, encephalin or dynorphin (endogenous opioid neurotransmitters). When 
activated, these neurotransmitters bind to μ-opioid receptors on the axons of 
incoming C and A-delta fibres carrying pain signals from nociceptors activated in the 
periphery. The activation of the μ-opioid receptor inhibits the release of substance P 
from these incoming first-order neurons and, in turn, inhibits the activation of the 
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second-order neuron that is responsible for transmitting the pain signal up the 
spinothalamic tract to the ventroposteriolateral nucleus (VPL) of the thalamus 
(Pertovaara & Almeida, 2006). Thus, by selectively stimulating the A β fibres it 
appears we can reduce the input from the nociceptive A Delta and C fibres in these 
laminae. The use of transcutaneous electrical nerve stimulation (TENS) is based, in 
part, on the Gate Control Theory. It is important to note that an analgesic effect is 
only created if the A β stimulation is in an anatomically similar region to the area of 
the nociceptor stimulation, as the respective afferents are required to converge at 
the same level in the dorsal horn in order to establish this “gating control” of pain 
(Basbaum & Jessel, 2000). The A β fibres are not directly activated by noxious stimuli, 
however they appear to contribute to the perception of the quality of the noxious 
stimulus. Therefore, in summary, activation of A β fibres contributes to perception of 
stimulus quality but also appears to attenuate it. 
 
2.3.2ii The descending pain modulatory system 
A network of neurons exists in the spinal cord linking the pain-related brain regions 
to the dorsal horn. This network modulates nociception at the dorsal horn, as a result 
of brain activity in these areas. Activation of the neurons can induce both an 
excitatory and inhibitory effect on nociception, with the overall effect being the net 
result of the facilitatory and inhibitory influences. Under normal circumstances this 
appears to be inhibitory however this balance can be easily influenced by various 
factors (Zusman, 2002) 
 
Nuclei involved in descending pain modulatory system 
The PAG, located in the mesencephalon around the Sylvius aqueduct, exerts a 
powerful pain modulatory action. Afferent fibres from the spinothalamic tract 
synapse at the PAG. Neural traffic from the PAG is connected to the spinal cord via 
the rostral ventromedial medulla (RVM). The RVM is a group of neurons located close 
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to the midline on the floor of the medulla oblongata. The RVM includes the nucleus 
raphe magnus (NRM) and adjacent reticular formation, including the nucleus 
gigantocellularis pars and paragigantocellularis ventralis, all of which project directly 
to the spinal cord. The PAG sends efferent connections to the nucleus raphe magnus 
when it is stimulated by opiates (Pertovaara & Almeida, 2006).  Both the PAG and 
RVM receive direct afferent projections from the spinal dorsal horn and, thus, they 
may control the ascending nociceptive input by a simple feedback mechanism.  
The rostral ventromedial medulla (RVM) sends descending inhibitory and excitatory 
fibres to laminae I, II and V of the dorsal horn spinal neurons. Three categories of 
neurons have been identified in the RVM: “Off-cells” which are inhibitory; “on-cells” 
which are facilitatory/nociceptive; and neutral cells which show no response to 
nociceptive input (Pertovaara & Almeida, 2006). That the spinal cord pain pathway 
neurons can assert a nociceptive and antinociceptive influence indicates the 
bidirectional nature of the brainstem descending modulatory system.  
The NRM receives descending afferents from the periaqueductal grey, the 
paraventricular hypothalamic nucleus, central nucleus of the amygdala, lateral 
hypothalamic area, parvocellular reticular nucleus and the prelimbic, infralimbic, 
medial and lateral precentral cortices. All of these brain areas influence the main 
function of the nucleus raphe magnus, that is, pain modulation. Projections extend 
to the dorsal horn of the spinal cord to directly inhibit nociception. When stimulated, 
the nucleus raphe magnus releases serotonin, a neurotransmitter which suppresses 
nociceptive input. 
 
Inhibition 
The descending inhibitory systems can impose an inhibitory effect on the ascending 
nociceptive signals but they can also serve to “focus” the painful signal by suppressing 
the surrounding extraneous neuronal activity, thereby reducing the level of “noise” 
in the nervous system (Zusman, 2002). Diffuse noxious inhibitory control neurons are 
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located in the caudal medulla (Lewis, Kersten, McCabe, McPherson, & Blake, 2007). 
Activation of these neurones is the mechanism by which the diffuse noxious 
inhibitory control system (DNIC) produces a top-down inhibitory effect on a painful 
stimulus. Descending inhibitory systems will serve to mask the “noise” of underlying 
pain when a “new” painful stimulus is applied in order to help focus the new painful 
stimulus (Zusman, 2002). Although DNIC involves a descending inhibitory influence, 
it has been postulated that the net effect of DNIC is clarification of pain perception 
evoked by the most threatening noxious stimulus (Pertovaara & Almeida, 2006). 
Clinical studies indicate that in patients with fibromyalgia a reduction of DNIC 
potentially contributes to hyperalgesia (Pertovaara & Almeida, 2006). 
The descending inhibitory tracts and nuclei may be activated by various mechanisms. 
Descending pain inhibitory pathways have an important role in the ascending–
descending circuitry, providing negative feedback control of nociceptive signals at the 
spinal cord level. Therefore, full activation of descending inhibition is observed only 
under painful conditions (Pertovaara & Almeida, 2006). Higher brain centres 
associated with cognition, motion, mood and behaviour recruit descending pain 
modulatory pathways. Some centrally-acting analgesic drugs are effective by 
inducing activation of descending pain inhibitory pathways (Pertovaara & Almeida, 
2006). 
The dorsolateral funiculus appears to be the main pathway for descending pain 
inhibitory systems between the RVM and dorsal horn (Zusman, 2002). There are 
several ways in which the descending inhibitory tracts suppress nociceptive signals: 
1. Neurotransmitters released from descending axons may block the ascending 
nociceptive signal by producing a hyperpolarization of spinal relay neurons 
(Pertovaara & Almeida, 2006).  
2. Descending pathways may also suppress nociceptive signals due to action on 
central terminals of primary afferent fibres (presynaptic inhibition). These 
terminals have receptors specific to the inhibitory neurotransmitters released in 
the descending spinal cord (Pertovaara & Almeida, 2006). 
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3. Gate Control theory of pain. The axons of the neurons within the dorsolateral 
funiculus terminate on inhibitory interneurons in the dorsal horn of the spinal 
cord. These interneurons, in addition to being subject to the segmental influence 
of peripheral origin in the Gate Control mechanism, may therefore also be subject 
to an activation of central origin. The interneurons in the dorsal horn exert their 
inhibitory effect by releasing endogenous opioids that act on specific receptors 
located both in the terminals of the primary nociceptive afferents and directly on 
the converging neurons, that is, pre-and post-synaptic inhibition. 
Activation of projections from the PAG to the brainstem nuclei (RVM and locus 
coruleus) and then to the dorsal horn of the spinal cord, involve neurotransmitters 
such as opioids, noradrenalin, and serotonin which have modulatory (both excitatory 
and inhibitory) influences on spinal cord afferent neurons. Opioids are strong 
analgesics which work at various sites within these descending tracts, preventing the 
passage of nociceptive signals through the dorsal horn and into higher levels of the 
brain where the perception of pain is generated (Basbaum & Jessel, 2000). 
 
Facilitation 
The nucleus reticularis gigantocellularis (NGC) in the medulla appears to be the origin 
of the descending facilitatory system. Activation in the NGC also appears to suppress 
the function of the inhibitory “off cells” in the RVM via inhibitory interneurons. A 
pathway exists between the dorsal reticular nucleus of the medulla and the dorsal 
horn of the spinal cord, which amplifies afferent nociceptive input and possibly 
contributes to central sensitization (Zusman, 2002). 
 
2.3.3 Supraspinal modulation of pain. 
There is evidence from functional magnetic resonance imaging (fMRI) studies 
showing that processing of nociception involves the activation of a diffuse network 
of transmitting fibre tracts and brain centres that are not exclusively devoted to pain 
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(Jabbur & Saadé, 1999). These centres receive afferent nociceptive input via multiple 
routes (Bushnell, Čeko, & Low, 2013). Prior to the production of the final pain 
experience the ascending afferent nociceptive signals are modulated supraspinally. 
A large number of brainstem, diencephalic (thalamic and hypothalamic) and 
telencephalic (cortical and sub-cortical) structures modulate pain through 
descending projections to the spinal dorsal horn, and in most cases their descending 
pain modulation effect is relayed through the PAG and the RVM (Pertovaara & 
Almeida, 2006). 
There is substantial evidence for pathways from these “pain-involved” cortical and 
subcortical regions to both the PAG and RVM to facilitate this supraspinal modulation 
(Zusman, 2002) and input from these centres most likely influences the balance of 
inhibitory versus facilitatory effects of the descending modulatory tracts. The RVM 
and PAG in the brainstem and the descending modulatory pain tracts play a pivotal 
top-down role in modulating the afferent nociceptive input prior to higher-order 
processing. These mechanisms of pain modulation influence the ultimate pain 
experience (Tracey & Mantyh, 2007).  
Connections between forebrain structures and the nuclei within the brainstem, 
particularly the RVM and PAG, have been identified. These include the ACC, IC and 
certain subcortical amygdala and hypothalamic nuclei (Zusman, 2002). Connections 
from higher centres of processing such as the S1, S2, posterior parietal, and insular 
cortices converge on the ACC together with connections from the prefrontal cortex 
(which is concerned with planning a response to the painful stimulus). The ACC, 
therefore, plays a major role in the integration of the sensory, affective, attentional, 
cognitive and emotional components of pain. Through its direct and indirect 
connections with the RVM and PAG, the ACC influences the descending modulatory 
system in a bi-directional manner and helps to explain how cognitions, beliefs, 
emotions, context and attention can influence our perception of pain (Zusman, 
2002). Particular personality traits, emotional states and cognitive styles lend 
themselves to the amplification and persistence of perceived pain via these 
connections from cortical /subcortical brain regions to the brainstem (Zusman, 2002). 
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2.4 Interaction between Pain and Emotional Factors 
Various pain-related pathways in the brain are responsible for different aspects of 
the pain experience. With recent advances in imaging we have been able to recognise 
various parts of the brain associated with the processing of the emotional component 
of a pain experience, and the various parts of the brain which appear to be activated 
by emotional states and exhibit a top-down modulatory effect on the afferent 
information.  The ACC and the insula are part of the limbic system of the brain which 
is primarily involved in a person’s emotional state. These regions are important for 
encoding the emotional components of pain (pain affect). They are linked directly to 
the PAG, and are commonly termed the “medial system” (Tracey & Mantyh, 2007). 
The amygdalae are almond-shaped nuclei in the temporal lobe of the brain, and are 
also part of the limbic system. They play an important role in emotional behaviour. 
Nociceptive afferent inputs through the spino–parabrachio–amygdala pathway 
probably contribute to pain-induced changes in affective behaviour. Likewise, the 
connections from the amygdala to the PAG and RVM may be involved in mediating 
the influence of emotions on pain. Stressful situations like physical exercise, exposure 
to extreme temperatures, fight, fear and pain may induce a decrease in pain 
sensitivity, a phenomenon called stress-induced analgesia. The hypothalamus is likely 
involved in stress-induced analgesia (Pertovaara & Almeida, 2006). 
The emotional component of the pain experience is powerful. Studies have shown 
that a noxious stimulus is not actually required to activate pain pathways and even 
to perceive pain, if a subject is adequately emotionally “primed”. This occurred in 
subjects while they were merely observing other individuals in pain (Lamm, Decety, 
& Singer, 2011). Also, when “emotionally primed” the subject’s perceived pain levels 
to a noxious stimulus was reported to be higher than without the priming (Loggia, 
Mogil, & Bushnell, 2008). 
It is difficult to induce a psychological state of anxiety/depression in the experimental 
environment and hence experiments are limited to inducing sadness or a depressed 
mood in subjects. In a study by Berna et al. (2010) subjects underwent a “sad” mood 
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induction process by means of reading “Velten-type” statements (commonly used to 
induce moods in psychological experiments) along with sad background music. They 
were deemed to have experienced a sad mood induction if they achieved a greater 
than 40% increase in their depressed mood score. The subjects were exposed to a 
noxious thermal stimulus and the brain activation patterns compared to those 
observed when the subjects were exposed to the same stimulus in a “neutral mood”. 
The results indicated that the induction of depressed mood augments the ratings of 
pain unpleasantness. The major difference noted using fMRI was the increased 
activity in the greater inferior frontal gyrus and amygdala in those subjects who 
reported the largest increase in pain unpleasantness. This demonstrates a potential 
link between changes in emotion control mechanisms and enhancement of pain. The 
researchers suggest that this may explain how depressed mood and chronic pain may 
co-occur  (Berna et al., 2010). 
Anxiety and depression are together referred to as “emotional distress” as it is often 
difficult to separate the two states diagnostically, particularly in children. The 
psychological states of anxiety and depression have been clinically demonstrated to 
augment the pain experience. It appears this is likely to be due to the increased 
attention focussed on the pain. For example, one study showed that subjects who 
were predisposed to anxiety and who were fearful of dental intervention both 
expected and experienced more pain than non-anxious subjects during restorative 
dental procedures (Klages, Kianifard, Ulusoy, & Wehrbein, 2006). Depressive 
disorders often accompany persistent pain (Tracey & Mantyh, 2007) and currently it 
is unclear which condition precedes the other. In an fMRI study of patients with 
fibromyalgia activation in amygdala and anterior insula differentiated patients with 
and without major depression, however the exact connections between pain and 
depression have not yet been determined (Giesecke et al., 2005).  
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2.5  Interaction between Pain and Cognitive Factors 
 The interaction between pain and cognitive factors has similarly undergone 
significant investigation. Studies have revealed that cognitive processes can influence 
pain behaviours and disability levels (Moseley, 2007). Cognitive processes appear to 
activate the superior parietal lobe, the insula and the S1 somatosensory cortex which 
is consistent with the role of these regions in pain sensation, rather than in pain 
affect. They are collectively termed the “lateral system” (Bushnell et al., 2013). These 
centres are linked to the ACC, PAG and RVM and thereby contribute to modulation 
of pain-evoked activity via the descending modulatory system (Zusman, 2002).  
Attentional focus seems to have a significant effect on acute pain perception. 
Through their experiments, Miron, Duncan, and Bushnell (1989) demonstrated that 
changes in the direction of attention alter the ability to discriminate noxious heat 
stimuli. They further provided evidence that both the speed and accuracy of 
detecting changes and the intensity and unpleasantness in noxious heat stimuli are 
decreased when the subject attends to another stimulus modality. Focus towards the 
nociceptive stimulus increases the pain experience while distraction decreases pain 
(Miron et al., 1989). Moseley (2007) reported contrasting effects of attention. The 
modulatory effect that attention has on pain perception seems to depend on the 
underlying threat value of the pain to that individual, and the measure of control the 
individual has over that pain. Nevertheless, despite the differences in direction of 
effect, there appears to be a strong modulatory effect of attention on the pain 
experience (Moseley, 2007). 
Pain distracts our attention from current activity. The amount it interrupts our 
attention is dependent on the intensity of pain or the perceived threat value. This 
turns our concentration towards the pain, which may result in a psychological state 
of hypervigilance (Vlaeyen, Crombez, & Goubert, 2007). In ongoing clinical pain states 
hypervigilance, which is characterised by excessive attention towards sensory 
information, augments our perception of pain (Vlaeyen et al., 2007) and has been 
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shown to explain some of the variance in pain severity and serve as a potential barrier 
to resolution in persistent pain problems.  
Attribution, anticipation and anxiety are cognitive factors that reflect aspects of a 
subject’s sense of control over a painful experience. In general, people with pain 
often seek to attribute their symptoms to a specific cause or diagnosis. As pain 
becomes more persistent, there is often no clear, physiological explanation for their 
symptoms. This leads to a sense of loss of control which has been demonstrated to 
augment the pain experience. In a study investigating the effect of a depressive-
attribution style in healthy male subjects, causal attributions for negative events 
were measured using the attribution style questionnaire (ASQ). A moderate 
correlation was demonstrated between the perceived pain intensity (PPI) of the 
electrical skin stimulus and the ASQ. Following uncontrollable stress exposure, the 
PPI increased significantly and there was a higher correlation between PPI and the 
ASQ (Müller, 2013). Anticipation and anxiety (as a trait) have also been shown to 
modulate the pain experience. Anticipating pain is adaptive and important to prevent 
potential injury. In an fMRI study, brainstem responses during anticipation and 
processing of thermal noxious stimuli were investigated. The intensity of perceived 
pain was shown to increase as the anticipation/ anxiety prior to the noxious stimulus 
heightened (Fairhurst, Wiech, Dunckley, & Tracey, 2007). 
Pain catastrophisation has been defined as a maladaptive “exaggerated negative 
mental set brought to bear during actual or anticipated painful experience”, and is 
thought to encompass the factors of helplessness, magnification and rumination 
(Sullivan et al., 2001). Others have emphasised that catastrophising about pain also 
encompasses “worrying about a major negative consequence from a situation, even 
one of minor importance” (Turner, Jensen, & Romano, 2000). Catastrophisation 
contributes to the pain experience and is associated with higher pain rating in both 
experimental and clinical studies. Individuals registering high scores on the pain 
catastrophisation scale report more intense pain (Sullivan et al., 2001), more severe 
depression and anxiety (Keefe, Brown, Wallston, & Caldwell, 1989), show higher 
levels of pain behaviour and disability (Sullivan, Lynch, & Clark, 2005) and have been 
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shown to predict higher perceived post-operative pain levels (Pavlin, Sullivan, Freund, 
& Roesen, 2005). It has been proposed that attention to pain underlies 
catastrophisation. This has been substantiated by neuroimaging data revealing 
increased activation in the cortical regions implicated in attention, vigilance and 
awareness. 
Expectation is the state of looking forward or anticipating a future occurrence. It is 
the degree of probability that something will occur. Recently, the placebo modulatory 
effect on pain was investigated as a form of inducing expectation (of relief) using a 
molecular imaging approach. The researchers confirmed that placebo analgesic 
effects are mediated by endogenous opioid activity on μ-opioid receptors. These 
observations were extended to confirm that prefrontal mechanisms can trigger the 
opioid release within the brainstem during expectancy to influence the descending 
pain modulatory system and subsequently modulate pain perception (Wagner et al., 
2007). 
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2.6  Multisensory Integration 
Besides the influence of cognition and emotion on our perception of pain, the 
intensity of pain may be influenced by the interaction from other sensory modalities, 
such as tactile, nociceptive, auditory, olfactory, gustatory, and visual input. This 
phenomenon is known as multisensory modulation (Haggard, Iannetti, & Longo, 
2013). There has been significant interest in exploring the influence of multisensory 
integration on the experience of pain. 
 
2.6.1 Modulatory effects of tactile activity on pain perception. 
 
The Gate Control mechanism of pain modulation discussed above, is a well-known 
example of multisensory modulation, whereby interactions between touch and 
nociceptive afferent stimuli at various levels, including the spinal cord, thalamus and 
cortex, reduce the intensity of pain perceived (Melzack, 1996).  
 
2.6.2 Modulatory effects of nociceptive activity on pain perception. 
 
The DNIC system is another example of multisensory modulation of pain, this time 
with acute nociception as the sensory input having a modulatory effect on underlying 
pain.  
 
2.6.3 Modulatory effects of auditory activity on pain perception. 
 
The effects of different auditory input on pain tolerance and pain intensity have been 
investigated by various groups. Music in different forms has been the most commonly 
described auditory input. 
Mitchell, MacDonald, and Brodie (2006) used experimentally induced cold pressor 
pain to compare the effects of subject-preferred music to two types of distracting 
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stimuli; mental arithmetic (a cognitive distraction) and humour (which may 
emotionally engage us in a similar manner to music). Preferred music listening was 
found to significantly increase pain tolerance time in comparison to the cognitive task 
and in comparison to humour. Ratings of pain intensity on a visual analogue scale and 
the pain rating index were not significantly different between the three distractions. 
So the investigators concluded that preferred music distracts attention from 
experimental pain significantly more than an affectively-neutral arithmetic task to 
allow for an increased tolerance time but not significantly more effectively than 
humour. The music used in this study was self-chosen and familiar, and therefore, 
individual preferences and familiarity could enhance the drive to listen attentively to 
the music and thus act as a distractor from the pain. The results also showed that 
preferred music provides a significantly greater feeling of control over a painful 
experience than a humorous distraction (Mitchell et al., 2006). These results were 
corroborated by work from the same group showing that familiar music increases 
pain tolerance more than unfamiliar music (Mitchell et al., 2006). 
Roy, Peretz, and Rainville (2008) developed a hypothesis that the mechanism 
underlying this established music-induced analgesia is mediated by the valence of the 
emotions induced by the music. Positive valence refers to the intrinsic attractiveness 
of the music while negative valence refers to the averseness. The results of this 
experiment varied from the above-mentioned in that the researchers found that the 
intensity of pain was affected, rather than just the subject’s pain tolerance. In their 
study, only the pleasant excerpts of music significantly reduced pain intensity and 
unpleasantness of a thermal stimulus, compared with unpleasant music and the 
silent control condition. Pain reduction was negatively correlated to the subjects’ 
reports of pleasantness of music. These results supported their proposal that 
pleasant music reduces pain more than unpleasant music (Roy et al., 2008). 
Subsequently, in a study involving a clinical population of fibromyalgia patients, pain 
ratings and timed-up-and-go tests were assessed while the subjects listened to self-
chosen, relaxing, pleasant music versus a control group who listened to an even/flat 
noise (termed “pink noise”). The experimental group demonstrated a significant 
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reduction in pain ratings and improved functional mobility compared with the results 
from the control group. The investigators went on to explain that the improved 
functional mobility was not related to an improved motor rhythm derived from a 
faster rhythm in the music because the effects were noted even if the music was 
played before the mobility assessment rather than during the test (Garza-Villarreal 
et al., 2014). 
Villarreal, Brattico, Vase, Ostergaard, and Vuust (2012) extended the above findings 
and demonstrated that valence of music alone is not an effective pain modulator. In 
their study an active distraction of a cognitive arithmetic task reduced pain more than 
the passive distractions with low arousal such as unfamiliar but pleasant music and 
unfamiliar but pleasant environmental sounds. Arousal refers to the physiological or 
psychological state of being awake or reactive to a stimulus. Although less effective 
than the cognitive task, the environmental sounds and music still had an analgesic 
effect and they reduced pain similarly to each other. Pain intensity was significantly 
correlated with valence and arousal (Villarreal et al., 2012). Therefore, valence and 
arousal are two interrelated emotional mechanisms that appear to be clearly linked 
to the analgesic effect of music. 
Pud and Sapir (2006) explored the influences of auditory stimulation and cognitive 
tasks on intensity of pain perception of normal subjects to a heat stimulus. A non-
music auditory stimulus in the form of a sinusoidally modulated speech-like signal 
was used. In this experiment, there was a significant difference in the visual analogue 
scale (VAS) ratings of the heat stimulus when the heat stimulus was applied in 
isolation, as opposed to being applied in conjunction with the auditory stimulus or 
with the auditory stimulus plus the cognitive task. The VAS rating dropped when 
there was competing sensory input/processing, demonstrating a significant influence 
of auditory +/- cognitive processing on the pain experience (Pud & Sapir, 2006). 
Dobek, Beynon, Bosma, and Stroman (2014) investigated the neural mechanisms 
underlying music-induced analgesia using fMRI. Noxious thermal stimulation was 
applied while subjects listened to their favourite music, or no music. Subjective pain 
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ratings were recorded while the spinal cord, brainstem and brain was scanned. In 
both the pain and pain with music condition neural activity was noted in areas 
consistent with previous experiments involving pain perception, however the pain 
with pleasurable music condition also involved activity in the limbic, frontal and 
auditory regions. This condition also demonstrated activity in the regions involved in 
the descending pain modulatory system, namely the dorsolateral prefrontal cortex 
(DLPFC), PAG, RVM, and the dorsal grey matter of the spinal cord. This gives a clear 
indication of the connections between auditory and pain perception and helps to 
explain the mechanisms underlying music-induced analgesia; namely activation of 
the descending inhibitory pathways. 
 
2.6.4 Modulatory effects of olfaction on pain perception. 
 
Raudenbush, Koon, Meyer, Corley, and Flower (2004) investigated whether odours 
could modulate subjects’ pain ratings and pain tolerance levels. Via a nasal cannula, 
they exposed the subjects to low-flow oxygen, peppermint odour plus oxygen, or 
jasmine odour plus oxygen while they underwent a cold pressor test. Subjects 
reported pain levels using a 0-10 scale every 30 sec, up to a maximum of 5 minutes. 
Following the cold pressor test, subjects also completed questionnaires related to 
mood (POMS), workload (NASA-TLX), and anxiety (STAI). The results indicated that 
peppermint and jasmine odour significantly decreased ratings of pain and increased 
overall pain tolerance. The questionnaires clearly reported positive influences by the 
odour conditions on the mood, workload and anxiety levels of subjects. Physiological 
changes were also observed. Oxygen saturation levels improved, pulse rate increased 
and blood pressure decreased during odour administration (Raudenbush et al., 
2004).  
The positive effects of odour on pain intensity ratings were supported by a recent 
study by Bartolo et al. (2013). They used the nociceptive withdrawal reflex (NWR), a 
defensive, protective response to a noxious stimulus as a reliable indicator of spinal 
nociception in humans, to explore the modulatory effects of odour on pain 
perception. They compared a pleasant odour, an unpleasant odour and a neutral 
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odour. The results indicated that both the NWR magnitude and subjective pain 
ratings were reduced by odours evoking pleasant sensations and increased by odours 
evoking unpleasant sensations. From this experiment, the investigators were unable 
to establish whether olfactory-modulation of pain exists as a result of direct 
connections between the primary olfactory enthorhinal cortex and spinal cord 
neurons or whether the modulation occurs indirectly by cognition, mood, anxiety, 
emotion, memories (Bartolo et al., 2013). 
A separate investigation aimed to establish whether odour-analgesia was related to 
hedonics of pleasantness or to a quality of the odour, specifically sweetness. The 
researchers assessed the effects on pain ratings and pain tolerance during application 
of a sweet-smelling odour, a pleasant odour, an unpleasant odour, and no odour. 
Again pain was evoked using a cold pressor test. The results indicated that odour 
sweetness rather than pleasantness increased pain tolerance. This may be through 
associative learning, through the frequent pairing of odours with sweet tastes. These 
results, however, dispute the findings of the above-mentioned studies in that odour 
itself was found to have no effect on pain intensity ratings. (Prescott & Wilkie, 2007).  
 
2.6.5 Modulatory effects of gustation on pain perception. 
 
Variable results have been observed when the modulatory effect of gustation on pain 
has been explored. This is particularly evident when the results of studies involving 
infant populations are compared to adult populations.  
In an experiment on newborns undergoing heel-stick procedures, pain was measured 
under four gustatory conditions: (a) water-moistened pacifier, (b) sugar-coated 
pacifier, (c) 2 cc of a 12% oral sucrose solution, or (d) control. Pain measures were 
duration of cry, vagal tone, and salivary cortisol levels. The results indicated that the 
babies with the sugar-coated pacifiers cried significantly less and they demonstrated 
significantly lower vagal tone than the babies in the other conditions. This difference 
was observed for fifteen minutes after the procedure. This suggests that the 
concentrated form of sucrose in the sugar-coated pacifier possibly modulated the 
pain experience. We cannot attribute the findings to the pacifier because one of the 
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other conditions involved the use of a water-moistened pacifier, which made no 
significant difference (Greenberg, 2002). That the 12% oral sucrose solution didn’t 
have a significant analgesic effect is likely to be due to the differences in 
concentration between the sugar-coated pacifier and the sucrose solution. The 
results from a review of studies examining the analgesic effects of sweet-tasting 
solutions for infants concurred with these findings (Harrison, Bueno, Yamada, Adams- 
Webber, & Stevens, 2010).  
Contradictory results are observed when the analgesic effect of sucrose is studied in 
adults. A more recent study compared modulatory effects of sweet, bitter and 
tasteless gelatine in the mouth of subjects who had experimental jaw muscle pain 
evoked by injection of hypertonic saline into the masseter muscle. The subjects 
continuously rated pain intensity as well as mood and unpleasantness/pleasantness 
of the conditioning stimuli. The gustatory stimuli failed to generate a robust change 
on the scores of emotions. No effects on pain intensity were observed during sweet 
or bitter gustatory stimuli. Based on pre-existing knowledge that emotions have an 
important modulatory effect on pain perception, the investigators concluded that the 
lack of pain intensity modulation during exposure to varied tastes was likely due to a 
lack of modulatory effects of gustation on emotions and the limbic system, and 
subsequently on the pain experience (Horjales-Araujo, Finnerup, Jensen, & Svensson, 
2013). 
 
2.6.6 Modulatory effects of vision on pain perception. 
2.6.6i Modulatory effects of vision on pain perception in a healthy 
population. 
Anticipation of pain in response to a visual stimulus appears to have a modulatory 
effect on perceived pain.  Visual input in peripersonal space modulates neural 
processes involved in predicting pain. One study showed that pain unpleasantness 
ratings were higher when the subject observed a needle approaching an embodied 
artificial hand, as opposed to a Q tip approaching the hand. The researchers felt the 
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expectation of pain was likely to have been responsible for the subjects’ increased 
pain unpleasantness perception (Höfle, Hauck, Engel, & Senkowski, 2012). 
A study by Martini, Perez-Marcos, and Sanchez-Vives (2013) showed that pain 
thresholds to a thermal stimulus were modified by changing the colour of an 
embodied virtual arm between blue, red and green. The subject’s pain threshold was 
lower when the virtual image was seen as red compared with when it turned blue. 
The visual input had a significant modulatory effect on the perceived pain which the 
investigators attributed to a top-down cognitive process of understanding the 
meaning of the visual input i.e. that red is associated with warmth and blue with cold. 
When the noxious thermal stimulus was associated with a red visual cue it was 
perceived as being hotter and hurt more than when the same stimulus was 
associated with a blue cue.  
Visualisation of one’s own body part while a painful stimulus is applied is a form of 
multisensory modulation which has attracted a lot of attention recently. The intensity 
of perceived pain can be affected by the content of visual input. In a study by Longo 
et al. (2009) subjects looked into a mirror aligned with the midline of their body at 
either a reflection of their left hand, another person’s left hand or at a reflection of a 
neutral object. The reflection of their left hand created the illusion that they were 
observing their right hand. The use of the mirror enabled the investigators to apply a 
painful stimulus to the right hand while the subject observed the illusion of their right 
hand but without the subject actually observing the application of that stimulus. In 
other words, the stimulus remained “non-informative”. After a 60 second induction 
period where the subject looked passively at the object reflected in the mirror, laser 
stimulation was used to selectively activate the nociceptive A Delta and C fibres, 
without activating mechanoreceptive afferents. Subjective pain ratings, using the 
VAS were collected while the stimulus was applied to compare any differences 
between visualising the painful body part and visualising a neutral object. A 
questionnaire was administered following each testing condition to determine what 
exactly the subject felt they were looking at in the mirror. Both the subjective ratings 
of perceived pain by the participant to cutaneous laser stimulation and the maximum 
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level of laser stimulation achieved reflected a reduction in perceived pain when the 
participant viewed their own hand, in contrast to viewing a neutral object. A variation 
of this experiment was included in the study where another person’s hand was 
reflected in the mirror instead of the subject’s. This part of the experiment 
demonstrated that the analgesic response is specific to observing one’s own hand, as 
opposed to another person’s hand. A second variation was also included which 
involved the subject looking directly at the right hand or at an object rather than a 
reflection of the left hand or object respectively. This part of the experiment was 
included to investigate the proposed mechanism underlying the analgesic effect; that 
of conflicting proprioceptive, sensory and visual representations produced by the 
mirror inhibiting pain. When the mirror was removed, the analgesic effect was still 
noted. The researchers therefore excluded this mechanism as the possible 
explanation behind the analgesic effect (Longo et al., 2009). 
It appears that pain and touch respond in contrasting ways to non-informative vision 
of a body part during noxious stimulation. Non-informative vision of the hand 
increases tactile acuity (Kennett, Taylor-Clarke, & Haggard, 2001), while in the 
experiment by Longo et al. (2009) pain ratings were lower with non-informative 
vision of the body part during noxious stimulation. A proposed explanation by Longo 
et al. (2009) for their experimental observations involved the visual-activation of 
GABAergic interneurons. GABA is a major neurotransmitter within the descending 
inhibitory system, thereby reducing perceived pain as a result of cross-modal 
modulation/inhibition. They cited the work of Kennett et al. (2001) who reported 
enhanced tactile acuity by visual modulation of somatosensory GABAergic 
neurotransmitters. Thus, they suggested that GABAergic interneurons are a likely 
effector of both improved tactile acuity and analgesia during this non-informed vision 
of the body part (Longo et al., 2009).  
It is also proposed that visual perception of one’s own body results in functional 
coupling between visual and parietal areas that may subserve multisensory inhibitory 
mechanisms. Longo, Iannetti, Mancini, Driver, and Haggard (2012) investigated the 
neural correlates underlying visual analgesia.  They used fMRI to assess the neural 
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activity of the brain during the visual analgesia phenomenon that they had previously 
described. They used an infra-red laser to stimulate the cutaneous nociceptors of 
normal subjects’ right hands, under two conditions. They compared the subjective 
pain ratings and the regional brain activity, while the subject was stimulated looking 
at a neutral object versus looking at their own hand. The visual analgesic effect was 
confirmed with analysis of the subjective pain ratings. The fMRI clarified the regions 
of the brain associated with visual perception, namely the bilateral posterior parietal 
cortices (PPC), lateral occipital and superior parietal cortices. Extensive activations 
bilaterally within the S1, S2, anterior insula, posterior insula, ACC and midcingulate 
cortex were observed during pain stimulation compared to a resting state. Therefore, 
there was little overlap between this and the pattern of activation noted during the 
visual perception. One common region that was activated in both scenarios, 
however, was the basal ganglia, particularly the caudate nucleus and the putamen. 
Thus the basal ganglia may provide the link between the visual system and 
nociceptive system to allow for pain modulation and subsequent visual analgesia. 
Their findings suggest that visually-induced analgesia does not result from a 
reduction in overall cortical responses to the painful stimulus but rather appears to 
be as a result of the activation of visual or bimodal visuo-tactile cells in the secondary 
somatosensory cortex (posterior parietal cortex). The investigators propose that 
sensory input such as vision causes these cells to activate inhibitory interneurons in 
the early somatosensory areas (S1 and thalamus) - regions associated with the 
perception of pain.  This was evident from the increased connectivity (i.e. functional 
coupling) observed between posterior parietal nodes of the visual body network and 
the structures comprising the pain matrix such as SII, anterior and posterior insula, 
and anterior cingulate cortex. This appears to occur much more quickly than the 
structural reorganizational changes associated with the development of chronic pain. 
Importantly, the pain experience was shown to be an emergent result of connectivity 
between multiple regions of the brain, rather than a direct read-out of nociceptive 
stimulation, within a specific pain matrix. 
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In 2015 Valentini et al. (2015) found that a vision induced  analgesic effect was only 
observed when the viewed body part was placed across the midline. Direct vision of 
the hand (as opposed to the mirror-box used in the study by Longo et. al. (2009)) in 
an uncrossed position alone and crossing the midline alone did not induce an 
analgesic effect, while together they did influence the intensity of the pain perceived. 
The analgesic effect observed with vision of one’s own body in a crossed position may 
be due to the augmented cognitive processing required to resolve the conflict 
between body-centred representation of the visual input and the egocentric spatial 
frame of reference. This would suggest that a combination of mismatched 
proprioceptive and visual representations may be worth incorporating into a pain 
management plan. 
Torta et al. (2015), suggested that the mirror-box, that was used in several previous 
studies to avoid the confounding effect of viewing the noxious stimulator, may 
contribute to the reported visual analgesia. They used a heat laser stimulator on the 
skin of the hand to compare the effects of “direct” vision of the hand versus vision of 
an illusion of the hand via a mirror-box on the intensity of pain ratings and on the 
event-related potentials (ERPs) elicited by nociceptive and non-nociceptive stimuli. 
They were unable to demonstrate visual analgesia or any effect on pain 
unpleasantness when viewing the hand either directly through a glass panel or a 
mirror-image of the hand, compared to when viewing a neutral object. They ruled 
out the possibility of the interposed glass causing the lack in observed visual analgesia 
by repeating the experiment. They compared pain ratings when observing the hand 
directly as opposed to through the glass panel and there was no significant difference 
observed.  However, they did observe greater nociceptive ERPs during vision of a 
neutral object compared to the hand, and greater non-nociceptive ERPs during vision 
of the hand compared to a neutral object.  The researchers stated that the changes 
in brain activity were unlikely to be linked to the concept of “visual analgesia” 
reported by Longo et al. (2009), as there was no change in perceived intensity 
observed in this experiment. This study raises further questions about what specific 
factors need to be in place to bring about visual analgesia. 
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2.6.6ii Modulatory effects of vision on pain perception in a clinical 
population.  
 
There are some indications that clinical pain may be subject to some of the same 
integration across multi-sensory modalities as seen with experimental pain. Wand et 
al. (2012) used a mirror with lower back pain patients to allow them to view their 
backs during pain-provoking lumbar spine movements. The view of their backs during 
movement proved to have an analgesic effect, demonstrating that visual analgesia 
potentially exists for clinical pain. The researchers did not investigate if magnification 
or minification of the viewed body part affected the analgesia. 
 
Diers et al. (2015) supported these findings in a chronic back pain population. Using 
real-time video feedback, subjects’ perceived pain intensity was reduced compared 
to viewing a neutral object, a video of another person of the same sex’s back or a 
static picture of their own back. The authors cited Longo et al. (2009) to explain their 
results, suggesting that the increase in the sense of agency by monitoring the painful 
body part would augment the subject’s body awareness potentially giving rise to top-
down pain reduction. There was no significant difference in reported pain 
unpleasantness. Interestingly, an analgesic effect was also noted when the subjects 
were tested with their eyes closed, however the authors feel that there were likely 
to be two different mechanisms underlying these effects. In conclusions, Diers et al. 
(2015) proposed that real-time video feedback of movement could be a simple and 
beneficial treatment modality to incorporate into the management plans of chronic 
pain patients.  
 
Visualisation was also documented to have an effect in a paper which describes a 
study, focussed mainly on improving two point discrimination (TPD) training success. 
Moseley and Wiech (2009) explored the effects of coupling visualisation of the painful 
body part with TPD training in a CRPS population, as opposed to TPD training alone. 
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Using a mirror-box to reflect the unaffected arm, there was a greater reduction in 
TPD threshold and pain levels post-training in the visualisation condition compared 
to the controls, however only the TPD difference lasted until the 2 day follow-up 
measurement. The pain relief was short-lived.  
 
2.6.6iii Effects of visual distortion of size on pain perception in a healthy 
population. 
Exploration of the effects of visual distortion of size on perceived pain has also gained 
momentum recently. Mancini et al. (2011) measured heat-pain threshold changes to 
assess the effect of visual analgesia under three different visual conditions. A mirror 
box was used to create the illusion of the ipsilateral hand, while that hand was 
stimulated with a thermal laser behind the mirror. In this experiment the visual 
condition was altered by replacing the normal mirror with a convex or concave mirror 
to produce a magnified or minified reflection respectively. The subjects were given a 
10-minute adaptation period in which they focussed on the reflected image. A fake 
laser probe was applied to the reflected hand to prevent perceptual conflict. 
Questionnaires were used after each condition to check that the mirror had induced 
the illusion of the hidden hand, that the various mirrors were effective in generating 
variances in the perceived size of the reflected hand and to monitor base skin 
temperatures. Pain threshold was assessed by asking subjects to press a pedal at the 
moment the heat stimulus became painful. This same experiment was then repeated 
but the hand to be reflected was placed inside a wooden box, so the reflected image 
was a neutral object instead of their hand, and the three visual conditions repeated 
again. The results of these experiments confirmed the findings of non-informative 
visual analgesia which was established in the previous experiment. But this 
experiment went on to show that visual enlargement of the hand enhanced analgesia 
and visual reduction of the hand decreased analgesia. This suggests a dose-response 
relationship to analgesia. With magnification of the perceived size of the body part, 
there was an increased analgesic effect, and vice versa.  
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A distinctive difference between the methods of pain ratings collected in this 
experiment and those used by Longo et al. (2009) is that the subjects had to push a 
pedal the moment they perceived the stimulus as painful, while Longo et al. (2009) 
used VAS pain ratings. These ratings would be generated after potential modulation 
by cognitive, emotional and multisensory influences but the pedal mechanism better 
isolates the sensory-discriminative component of the pain before modulation comes 
in to play. Despite this, similar effects were observed, which demonstrates that 
visualising the body part modulates the sensory-discriminative component of the 
pain experience in the early somatosensory areas (Mancini et al., 2011). 
One explanation for the mechanism underlying non-informative visual analgesia and 
for the increased analgesic effect noted when the body part is magnified is that there 
is increased attention turned toward the body part, which would have cognitive 
modulatory (inhibitory) effects on the pain experience. However, that a reduction in 
analgesia is observed in the minified condition disputes this as there is also likely to 
be increased attention drawn towards a body part that is viewed as unusually small. 
Osumi et al. (2014) showed that visual analgesia and analgesia due to visual distortion 
of size of the affected body part are not necessarily standard responses. They 
explored the factors associated with modulation of pain by using the magnifying 
mirror-box technique employed by Mancini et al. (2011). Subjects were divided into 
two groups according to their pain threshold responses to the magnified condition.  
Subjects who displayed a higher threshold to the thermal stimulus also displayed 
more vivid somatosensory perception (two-point discrimination) and presented with 
a neutral emotional response to the view of the magnified hand. Subjects who 
displayed a lower pain threshold in response to the magnified condition were 
separated into the “low-threshold” group and this response was found to be 
associated with no significant difference between TPD in actual and enlarged size 
conditions, and with a more negative impression of the magnified image of the hand 
compared to the “high threshold” group. There was also a strong negative correlation 
between the differences in feelings towards the enlarged hand and the Body Attitude 
Questionnaire (BAQ) scores in both conditions.   
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While interesting and compelling, these above-mentioned studies were performed 
on healthy populations, using experimentally-induced cutaneous pain. The 
methodology employed only inflicted noxious stimuli in superficial structures. Most 
clinical pain presenting to physiotherapists are likely to be contributed to by noxious 
input from deep tissues (Bove et al., 2005), so exploration of the effects of visual 
distortion of size on deep tissue pain and clinical pain conditions is important. 
 
2.6.6iv Effects of visual distortion of size on pain perception in a clinical 
population. 
An exploratory experiment, using real-time video capture of subjects’ hands, was 
able to manipulate the perceived size of painful and non-painful parts of the hand in 
an attempt to modulate pain experienced by twenty osteoarthritis sufferers (Preston 
& Newport, 2011). The study demonstrated that both stretching and shrinking the 
painful parts of the hand had an analgesic effect, halving the pain in 85% of the 
subjects. This effect was not witnessed when the entire hand or non-painful parts 
were stretched or shrunk (Preston & Newport, 2011). It is interesting that the 
analgesic effect was observed in both the shrunken and enlarged conditions. The 
authors propose that two distinct mechanisms could underlie these two effects, with 
the possibility that placebo could play a role in them. This research demonstrated 
that visual distortion of size has a modulatory effect on perceived clinical pain and 
that the use of visual illusions created using real-time video may be a potentially 
beneficial form of treatment for chronic pain sufferers. 
A study by Moseley et al. (2008) revealed contrasting effects of visualisation and 
visual distortion of size in a clinical population of subjects with CRPS of a unilateral 
upper limb. Under four visual conditions, a small sample size of ten subjects watched 
their painful arm while they performed a program of ten hand movements at a pre-
determined and standardised speed and amplitude. The four conditions involved 
looking at their arm: 1) normally, 2) through clear glass, 3) through magnifying 
binoculars, and 4) though minifying binoculars. The results indicated that the 
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magnified view of the limb significantly increased the perceived pain and extended 
the time for return to resting pain levels. Pain was least when they viewed the 
minified image of their arm during movements and recovery to pre-task pain was 
quickest under this condition (Moseley et al., 2008).  
Working with an upper limb amputee suffering from significant phantom limb pain 
Ramachandran et al. (2009) were able to alleviate the phantom sensation and 
phantom pain of the elbow, wrist and proximal palm leaving the distal palm and digit 
pain unaffected. This was achieved by the subject attempting to perform symmetrical 
movements of both upper limbs while observing a reflection of the intact limb in a 
mirror-box.  They explored changing the perceived size of the phantom limb with 
magnifying and minifying lenses, and found that magnification condition made no 
difference to the resting phantom pain, while shrinking the size of the phantom limb 
dramatically reduced the perceived pain. When the subject shut his eyes his pain 
returned immediately. This experiment confirmed in a clinical population the “visual 
analgesic” effect proposed by Longo et al. (2009) however, as reported by Moseley 
et al. (2008) the effects of visual distortion of size were in contrast to those found by 
Mancini et al. (2011). Perhaps the difference lies in the clinical pain populations 
studied. 
Several significant differences exist between chronic and acute pain mechanisms 
(Phillips & Clauw, 2011). These may explain the different findings. In CRPS subjects 
the size and territory of the brain region which represents the affected limb has been 
seen to change (Lewis et al., 2007). Also, an impaired body image and sense of 
ownership have been linked to chronic pain syndromes (Lewis et al., 2007). These 
findings may well underlie the variances in effects noted. An alternative explanation 
may be the significant differences which appear to exist between superficial and deep 
tissue pain. Comparison between superficial and deep pain mechanisms is therefore 
warranted and necessary. 
 
  
 50 
 
2.7  Deep versus Superficial Pain 
Pain that arises from noxious stimulation of deep tissues appears to be quite different 
to pain that arises from noxious cutaneous stimulation, not only subjectively but also 
from a neuroanatomical and mechanistic perspective. 
Witting, Svensson, Gottrup, Arendt-Nielsen, and Jensen (2000) compared pain from 
noxious skin stimulation to pain from noxious muscle stimulation, using equal stimuli 
of capsaicin. This study showed that cutaneous pain varied significantly to 
intramuscular pain in several ways. They found the quality of cutaneous pain to be 
commonly described as sharp, while muscle pain to be described as dull, throbbing, 
and less intense. Cutaneous pain tends to be well localised which is important for 
protection. A fast motor response can often remove an external noxious stimulus. 
Muscle pain was observed to be less localised (Witting et al., 2000). A separate study 
noted that while muscle pain is difficult to localise, pain arising from other deep 
structures, such as periostea and fascia was actually well localised (Staff, 1988).  
Peripherally, if the stimulus is strong enough, muscle pain can result in referred pain 
to subcutaneous structures distant to the site of the stimulus and the muscle being 
stimulated, while superficial pain does not demonstrate this phenomenon (Witting 
et al., 2000). Viscera were also shown to refer pain, however they appear to refer 
pain only to the skin (S Mense & Simons, 2001). Another observation was that the 
pain experience was reported to last longer when muscles are stimulated compared 
with when superficial tissues are exposed to the same painful stimulus (Witting et al., 
2000).  
At the spinal level, muscular pain differs from cutaneous pain in that the excitatory 
effects of unmyelinated A  Delta afferent fibres from muscle are subject to a strong 
segmental inhibition by myelinated A β afferent fibres. This inhibition is not observed 
with activation of the cutaneous C fibres (S. Mense, 2003). 
In the central nervous system, nociceptive signals from muscle and skin are processed 
differently. The afferent nociceptive fibres from muscular tissue terminate in the 
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ventral PAG while those from the skin terminate in the lateral PAG (Keay & Bandler, 
1993).  A separate study showed there is not one specific region in the brain activated 
by muscle pain however the S2 was specifically activated by nociceptive cutaneous 
stimuli (Uematsu, Shibata, Miyauchi, & Mashimo, 2011). These differences that have 
been observed in the processing of superficial and deep nociception may explain the 
variance seen in the descending modulation of deep and superficial nociceptive 
signals. 
Activity in the descending pain-modulatory pathways was found to influence the 
superficial and deep tissue nociceptor afferents differently. Spinal neurons with 
afferent input from deep tissues were observed to be located in the superficial dorsal 
horn and in and around lamina V, and were more strongly affected by the descending 
inhibition than cutaneous input to the same neuron (Yu & Mense, 1990). It was also 
observed that when descending pain-modulating pathways were experimentally 
interrupted, the observed activity in the ascending nociceptive pathways distal to the 
site of interruption is not equal between the cutaneous and deep nociceptor 
afferents. The activity was higher in neurones with input from deep nociceptors than 
in cells mediating cutaneous nociception (S. Mense, 2003). The two mechanisms are 
affected differently when descending inhibition is disrupted.  
These differences demonstrate why the findings of experiments involving 
cutaneously-induced pain should not be directly applied to deep tissue pain. It 
appears that deep tissue and superficial tissue mediated pain mechanisms are 
considerably different from each other.  
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2.8  Summary of Literature Review 
Over the past four decades, our concepts of mechanisms underlying pain have 
evolved radically to the point where we now believe pain to be a complex interaction 
of multiple inputs creating a subjective, multidimensional, emergent experience 
(Breen, 2002).  
Nociceptors are sensory receptors that detect noxious stimuli. They respond to 
extreme and potentially damaging mechanical, thermal and chemical stimuli. The 
dorsal horn of the spinal cord is the ultimate target and relay station for the primary 
nociceptive afferents and the impulses conveyed by them. Despite the distinct 
laminae within the dorsal horn, there are branched collateral connections which are 
likely to allow for ‘cross-talk’ between nociceptive and non-nociceptive afferents at 
this level. It is thought that these potential connections may play a role in pain 
modulation (Basbaum & Jessel, 2000). 
According to Basbaum and Jessel (2000) there are regions in the cerebral cortex 
which respond exclusively to nociceptive input. However a review by  Legrain et al. 
(2011) disputed this and proposed that the areas that were once thought of as 
nociceptive specific are better thought of as salient specific. Nociception is just one 
of many types of salient information that gives rise to a particular salient specific 
neurosignature. ERPs elicited in response to a salient stimulus involve three 
processes, namely the detection, localisation and reaction to the salient and 
potentially dangerous physical threat 
Nociceptive input is modulated by various factors at various levels which can allow 
for the production of a very different pain experience which is not only reflective of 
what is occurring at the tissue level. Modulation appears to occur in the periphery at 
the nociceptor terminals, within the laminae of the dorsal horn, and in supraspinal 
centres.  
Besides evidence of the influence of cognition and emotion on our perception of pain, 
the intensity of pain may be influenced by the interaction from other sensory 
 53 
 
modalities, such as tactile, nociceptive, auditory, olfactory, gustatory, and visual 
input. This phenomenon is known as multisensory modulation (Haggard et al., 2013). 
There has been significant interest in exploring the influence of multisensory 
integration on the pain experience, particularly vision, over the past several years. 
Longo et al. (2009) showed that observation of the actual body part while an unseen 
painful stimulus is applied topically to that body part has an analgesic effect, as 
opposed to observation of a neutral object. They adopted the term “non-informative 
analgesia” as the stimulus is not visualised. This experiment was carried out in a 
healthy population.  
Wand et al. (2012) used a mirror with lower back pain patients to allow them to view 
their backs during pain-provoking lumbar spine movements. The view of the subjects’ 
backs during movement proved to have an analgesic effect. 
Diers et al. (2015) supported Wand et al. (2012) findings by observing visual analgesia 
in a chronic back pain population, demonstrating that the intensity of perceived back 
pain could be reduced by subjects simply watching their backs on a video screen. 
However, Torta et al. (2015) did not observe visual analgesia when subjects viewed a 
mirror image of their hand or their hand directly, when compared to a neutral object.  
Valentini et al. (2015) recorded an analgesic effect only when viewing the hand was 
combined with the hand crossing the midline. No analgesia was experienced with 
visualisation alone in their study.  
The effects of visual distortion of body size on pain perception have also been 
explored, with mixed results. Mancini et al. (2011) proposed a dose-response 
relationship to visual analgesia. With magnification of the perceived size of the body 
part an increased analgesic effect was observed whereas minification of the body 
part reduced the analgesic effect. Preston and Newport (2011) also reported a 
significant analgesic effect when the size of the view of the painful part of the hand 
in osteoarthritic sufferers was altered using real-time video. 
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More recent findings by Osumi et al. (2014) have suggested modulation of pain by 
visualisation is not a definitive response and is associated with certain conditions 
being in place. They found that subjects’ somatosensory vividness (TPD) was reduced 
and a neutral emotional response was displayed by the subjects who demonstrated 
a higher pain threshold in the enlarged condition compared to the actual size 
condition. Subjects with strong obsessiveness towards the shape and appearance of 
their own bodies (as reflected by the BAQ scores) displayed negative feelings towards 
the magnified mirror visual feedback and these factors were found to be associated 
with a reduction in pain threshold in the magnified condition.  
These articles suggest that visualisation, and particularly visual magnification of the 
painful body part might have some therapeutic value in the management of clinical 
pain states, although findings by Moseley et al. (2008) and Ramachandran et al. 
(2009) in CRPS patients and phantom limb pain patients respectively contradict 
these. They observed a modulatory effect of visual distortion of size however this was 
in the opposite direction to Mancini et al. (2011). Mechanisms underlying these two 
unique chronic pain syndromes may, however, operate differently and account for 
the different results observed.         
The studies by Longo et al. (2009),  Mancini et al. (2011) and Osumi et al. (2014) 
involved the application of noxious stimuli to the skin of subjects. It is thought that 
most clinical pain is contributed to by noxious stimuli from deeper tissues. Despite 
this, to date there have been no studies researching the effects of visualisation and 
visual distortion of size on experimental deep tissue pain. These questions are the 
topic of this thesis: 
1. Does visualisation of the painful body part have an effect on deep tissue pain? 
2. Will pain perception be modified by visual distortion of the size of the viewed 
quadriceps muscle, in the form of magnification? 
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CHAPTER THREE: PILOT STUDY 
 
 
This study investigated the stability of the outcome measures used to assess 
experimental deep tissue pain in the form of Delayed Onset Muscle Soreness (DOMS).  
We also required data obtained from the pilot study to inform the power calculation 
for the primary study. 
Eccentric exercise is a well-established method of inducing deep tissue soreness 
(Cheung, Hume, & Maxwell, 2003; Law et al., 2008). The exact mechanisms 
underpinning the pain experienced are not yet fully described, however DOMS is 
viewed as the perceptual correlate of a muscle adaptive process (Malm, 2001) 
induced by a novel bout of loaded, lengthening eccentric contractions. Typically 
delayed soreness peaks between 24 and 48 hours post exercise reaching complete 
resolution by day five to seven post exercise (Abraham, 1977) 
While DOMS as an endogenous model of deep tissue pain has been widely used as 
an experimental methodology utilised to investigate deep pain, there is a dearth of 
information regarding the stability of the pain responses evoked during DOMS 
perception. Currently there are no data on the temporal reliability of the pain 
responses to movement or mechanical stimulation. This study therefore investigated 
the reliability of repeated evoked pain responses (over the course of 1 hour) to a 
standardised contraction in a DOMs affected muscle. Further, this pilot study 
provided data that informed the power calculations of the main study project. 
Observation over the period of one hour was chosen as this was anticipated to be the 
length of time required for the testing procedure in the second session of the primary 
study. If the intensity of pain was demonstrated to remain constant then any changes 
in intensity experienced in the second session of the primary study could not be 
attributed to time and could therefore be attributed to the various visual conditions 
experienced by the subjects. 
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3.1 Study Design and Methodology 
A repeated-measures within-subjects design was used in this pilot project. Ethics 
approval was obtained from the HREC of The University of Notre Dame Australia 
(Reference number: 014036F) and all participants provided written informed 
consent. 
DOMS was induced in either the left or right quadriceps muscle of involved 
participants. A key feature of the primary study in this project was the requirement 
to be able to observe the sore body part. Quadriceps and forearm extensors were 
therefore considered ideal in this regard (as opposed to Triceps or Gastrocnemius for 
example). Test exercise revealed inconsistency in the level of DOMS induced in the 
forearm muscles, therefore this study focussed on DOMS in quadriceps muscle. The 
non-dominant limb was chosen for DOMS induction to standardise our procedure 
and also because the non-dominant limb was likely to be less conditioned than the 
dominant limb and hence yield more consistent delayed onset soreness responses. 
 
3.1.1 Participants. 
Ten healthy volunteers participated in this project. The researchers worked directly 
within their personal networks to identify individuals to participate in this study. 
Inclusion criteria for the pilot study: aged between 18 and 50 years, proficient in 
written and spoken English and the ability to provide informed written consent. 
Participants were excluded if they suffered ongoing lumbar spine problems, 
experienced abnormal tenderness to palpation of the soft tissues of the thigh, 
presented with reduced or excessive knee or hip movement, had suffered leg pain 
that required a visit to a health care professional within the previous 12 months or 
had sustained a fracture or dislocation of the leg within the last five years. They were 
also excluded if they had any ongoing medical or neurological conditions, consumed 
regular anticoagulant medication or medications known to influence pain sensitivity 
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(e.g. painkillers, anti-inflammatories, anti-depressants) or if they had recently trained 
the quadriceps with eccentric strength exercises (within the previous six months). 
 
3.1.2 Experimental procedure. 
Each subject attended two sessions 48 hours apart.  
 
Session one. 
The purpose of the 1st session was to collect subject demographics and to guide the 
subject through an exercise protocol which had been developed to induce DOMS in 
the non-dominant quadriceps muscle. 
At the first visit, subjects received a Plain Language Statement which explained the 
process of the study and the implications of their participation. Informed consent was 
obtained and basic demographic information collected. The procedure of the study 
was explained, the subject’s maximal isometric knee extension strength was 
determined, and they were then supervised in a one-on-one manner by the 
researcher through the exercise protocol aimed at inducing DOMS.  
 
3.1.2i Maximal isometric knee extension strength. 
The participant’s maximal isometric strength of the non-dominant quadriceps muscle 
was established. This was performed with the subject in a seated position with knees 
and hips flexed to 90 degrees and feet flat on the floor. The subject extended the 
non-dominant knee until they were at a point 10⁰ off full knee extension. The 
assessor then positioned a hand-held dynamometer against the anterior aspect of 
the distal tibia, just proximal to the talo-crural joint line.  The subject was asked to 
attempt to extend the knee into full extension while the assessor resisted this action, 
resulting in a maximal isometric contraction. Once the dynamometer registered the 
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greatest force generated during the contraction the machine produced a “beep” 
sound which indicated the reading had been taken and the subject could relax. This 
was repeated 3 times to ensure consistency, with the average of these three scores 
being used to establish the sandbag weights required for resistance in the testing 
session (see “Testing procedure”).  
 
3.1.2ii Exercise protocol to induce DOMS. 
The participants undertook a protocol aimed at inducing DOMS in the non-dominant 
quadriceps muscle group. This involved the subject performing 150 repetitions, 
leaning backwards as far as possible in a slow and controlled manner from a half 
kneeling position (see Figure 1), then returning  to the start position with assistance 
from the researcher.  
 
Figure 1. Exercise starting position 
This figure illustrates the half kneeling position assumed during DOMS-inducing exercise 
session. 
 59 
 
The direction and speed of the backward lean was controlled by eccentric 
lengthening of the quadriceps muscle on the side the subject was kneeling on.  The 
researcher acted as a ‘spotter’ during the eccentric component of the task to ensure 
safety. The 150 repetitions were divided into five sets of 30 repetitions, and the 30 
repetitions were performed as three sets of ten. Subjects had a 30 second break 
between each set of ten repetitions and a two-minute break between each of the five 
sets.  
 
Plain language statements sent by email to subject prior to first session 
↓ 
Arrival of subject at first session 
↓ 
Procedure of session explained verbally 
↓ 
Written consent obtained, demographics collected 
↓ 
Maximum isometric quad strength at -10⁰ off full extension established 
↓ 
Exercises completed 
Figure 2. Flow diagram to represent sequence of events at subjects’ first visit. 
 
Session two. 
The 2nd session took place 48 hours later. The purpose of this session was to 
determine subject eligibility to participate in the study and to assess the levels of pain 
evoked at 15 minute intervals with a view to establishing the stability of the outcome 
measures used to assess experimental deep tissue pain in the form of DOMS.  
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Subject’s completed a validated Likert scale and then, if included in the study, 
underwent the testing procedure.  
 
3.1.2iii Likert scale. 
Upon arrival at the 2nd session, 48 hours later, subjects were asked to complete a 
previously validated Likert scale of delayed onset muscle soreness that recorded their 
perception of soreness experienced at that moment in time (see Appendix 3 for the 
full data Collection template) (Slater, Arendt-Nielsen, Wright, & Graven-Nielsen, 
2005). They needed to score ≥ 3 to be included in the testing procedure. 
 
1 A light soreness in the muscle felt only when touched/ a vague 
ache 
2 A moderate soreness felt only when touched/ a slight persistent 
pain 
3 A light muscle soreness while walking up and down stairs 
4 A light muscle soreness when walking on a flat surface 
5 A moderate muscle soreness, stiffness or weakness while walking 
6 A severe muscle soreness, stiffness or weakness that limits my 
ability to move 
Figure 3. Modified Likert Scale of muscle soreness 
(Andersen, Arendt-Nielsen, Svensson, Danneskiold-Samsøe, & Graven-Nielsen, 2008). This 
scale was used by each subject to reflect their level of soreness at the second session. 
 
3.1.2iv Testing procedure: evoked pain during DOMS. 
The testing involved the subject performing quadriceps contractions at 15 minute 
intervals across the period of one hour and rating the pain evoked by these 
standardised contractions. Pain was rated using a numerical rating scale (NRS). 
Immediately following each standard contraction the participant was shown a 10cm 
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long NRS with zero anchored by ‘no pain’ and 10 with ‘maximum pain’. Participants 
provided one NRS score following each contraction. Participants were placed in a 
seated position; feet flat on floor, hips and knees flexed to 90°. The load for each 
subject was standardised by calculating 40% of the average force recorded during the 
maximal isometric contractions completed during session one 48 hours previously. A 
sandbag of this established weight was attached to the distal tibial using a Velcro 
strap. The researcher then passively extended the affected knee joint. From this 
position the subject was then verbally guided to perform a controlled lowering of the 
foot towards the floor, allowing flexion of the knee toward 90° over the period of 3 
seconds. This movement required eccentric lengthening contraction of the DOMS 
affected quadriceps muscle. This procedure was repeated three times and between 
each of the three repetitions the assessor extended the knee passively, returning it 
to the starting position of full knee extension. The visual conditions were identical 
across each test period in that the subjects looked straight ahead focussing on the 
same object during each repetition.  After three contractions the sandbag was 
removed and the subjects were given a 15 minute washout period. This process was 
completed at the 15 minute mark, 30 minute mark, 45 minute mark and 60 minute 
mark (four sets of three contractions in total). 
If, during the testing process, the subject rated their pain consistently as zero out of 
ten on the NRS, then the subject was excluded from the study. 
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Subject scored pain according to Modified Likert Scale (appendix 3) 
        ↓                                                                                  ↓ 
Score  ≥3                                                                    Score < 3 
        ↓                                                                                  ↓ 
Included in study                                                   Excluded from study 
                             ↓                                                                                           
15′ point: Sandbag attached around distal tibia. 
3 submaximal eccentric repetitions performed, subject looking straight ahead. 
Subject scores each contraction /10 on NRS 
                              ↓ 
Sandbag removed for washout period 
                              ↓ 
30′ point: Sandbag attached around distal tibia. 
3 submaximal eccentric repetitions performed, subject looking straight ahead. 
Subject scores each contraction /10 on NRS 
                              ↓ 
Sandbag removed for washout period 
                              ↓ 
45′ point: Sandbag attached around distal tibia. 
3 submaximal eccentric repetitions performed, subject looking straight ahead. 
Subject scores each contraction /10 on NRS 
                               ↓         
Sandbag removed for washout period 
                               ↓ 
60′ point: Sandbag attached around distal tibia. 
3 submaximal eccentric repetitions performed, subject looking straight ahead. 
Subject scores each contraction /10 on NRS 
                               ↓ 
              Sandbag removed  
 
Figure 4. Flow diagram to represent sequence of events at subjects’ second visit. 
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3.1.3 Ethical considerations. 
Experimental induction of pain in human subjects is obviously fraught with ethical 
considerations. It is important that any pain induced is transient and does not 
represent injury or damage to tissues. In essence, the primacy of benefits 
outweighing risks has to be respected.    
To fulfil these requirements in this research study it was decided to induce DOMS, 
which is a usual response to unaccustomed exercise that includes a preponderance 
of eccentric muscle actions. 
With any form of exercise, there may be some risk of sustaining a musculoskeletal 
injury. The researchers believed that the risk of injury in this case was highly unlikely 
due to the type of exercise that was to be performed and the fact that the conditions 
would be controlled under the direct guidance of a Physiotherapist. The DOMS would 
likely cause some short-term discomfort (peaking at approximately 48 hours) in the 
thigh muscles of the non-dominant leg, before starting to dissipate. However 
previous research has shown that there are no long-term adverse effects from DOMS; 
in fact DOMS has been shown to be of benefit to the musculotendinous unit in the 
long-run, and high load eccentric exercise is used in the rehabilitation of common 
musculoskeletal conditions such as tendinopathy (Alfredson, 2003). In some cases 
and under some conditions DOMS has been shown to be of benefit to the participant 
in terms of longer term muscle development and function (Brockett, Morgan, & 
Proske, 2001). Thus, while exercise in this study was very specific, it was also very 
well controlled with the perception of soreness dissipating within a short period of 
time (e.g. maximum of seven to ten days) and protecting the muscle from subsequent 
DOMS from the same stimulus for up to six weeks. 
Participation in the study was only accepted if there was very minimal risk associated 
with undertaking the tests involved and that the participant satisfied the criteria for 
participation. The subjects were free to stop the testing and withdraw from the study 
at any time and to withdraw any unprocessed data previously supplied. 
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If any adverse events arose, the chief-investigator was to arrange Physiotherapy or 
Medical management at location which is convenient for the participant at the 
expense of the co-investigator. The participant’s condition was to be closely 
followed-up and monitored by the co-investigator. There were no foreseeable risks 
to the researchers. 
The benefit of conducting this research was that a better understanding of the 
mechanisms of deep tissue pain would be gained, and this in turn could potentially 
contribute to treatment modalities targeting pain. As explained, this knowledge was 
gained at very low risk to the subjects. This study received Ethical approval by the 
Human Research Ethics Committee of the The University of Notre Dame Australia, 
Fremantle (Reference number: 014036F) (Appendix 5). 
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3.2  Data Analysis  
3.2.1 Exploration of data and tests for normality. 
Descriptive statistics were used to present demographic information and pain 
intensity scores following each contraction for each condition. Normality of 
distribution was assessed by visual inspection of Q-Q plots and further investigated 
with Shapiro-Wilk tests for normality. All results were reported as Mean ± SD. A p-
value of <0.05 was considered to represent statistical significance. All data were 
analysed using IBM SPSS Statistics 23.0 software. A statistician was consulted to assist 
with this process. 
 
3.2.2 Stability of pain scores over the period of an hour. 
A one-way repeated measures ANOVA was performed to compare pain scores (NRS) 
across the hour i.e. at 15 minutes, 30 minutes, 45 minutes and 60 minutes. 
 
3.2.3 Reliability of pain intensity ratings across the period of an hour. 
Temporal reliability of pain intensity across the four trials was evaluated using a two-
way mixed model intraclass correlation co-efficient ICC(3,1) with absolute agreements. 
Preliminary analyses were performed to ensure no violation of the assumptions of 
normality, linearity and homoscedasticity.  
 
3.2.4 Sample size and minimal detectable difference size calculations. 
 
The within-subject difference in mean pain intensity ratings (NRS) across the four 
time points was estimated and used as the minimal detectable change in the power 
calculation for the primary study. 
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3.3  Results 
3.3.1 Exploration of data and tests for normality. 
A total of ten subjects (three males, seven females) volunteered to participate. The 
mean age was 40.5 years ± 2.80. Every participant rated their pain at a level of three 
or greater on the Modified Likert Scale at the beginning of Session two (Appendix 3), 
which meant every subject could be included in the testing component of the 
experiment.  
The lowest pain score reported across the four testing sessions was 1 out of 10 and 
the highest was 8.5. The mean pain score and standard deviations across the four 
contraction repetitions are listed in Table 1 below. Visual inspection of boxplots of 
each test occasion indicated no outliers and Shapiro-Wilks test for normality 
demonstrated a normal distribution for all tests (p>.05). 
 
Time Mean ± SD 
15 minutes 4.37 ± 2.34 
30 minutes 4.10 ± 2.02 
45 minutes 4.20 ± 2.26 
60 minutes 4.23 ± 2.26 
Table 1. Mean and Standard Deviations of NRS pain scores across contractions 
 
3.3.2 Stability of pain scores over the period of an hour. 
A one-way repeated measures ANOVA was conducted to determine whether there 
were statistically significant differences in NRS rating across the four testing 
occasions. Mauchly’s test of sphericity was not significant (p>.05) indicating the 
assumptions of sphericity had been met. The NRS ratings did not change significantly 
over time (F3,27 = .459, p=.713) with mean pain scores listed in Table 1 above. 
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3.3.3 Reliability of pain intensity ratings across the period of an hour. 
 
In the two way mixed model intraclass coefficient calculation with absolute 
agreements for the four testing occasions, the sample was deemed the random effect 
while the repeated rating by the individual was considered the fixed effect. The 
ICC(3,1) =.987 indicated extremely high reliability across the testing occasions. 
 
3.3.4 Sample size and minimal detectable difference size calculations. 
 
Based on data from the pilot study we estimated a within-subject difference in means 
of 0.3 on the pain intensity NRS. This was used as the threshold for determining the 
minimal detectable change in the power calculation for the primary study. The power 
of a cross-over design using a minimal detectable difference of 0.3 achieved 90% 
power when a minimum of 17 subjects were recruited, the standard deviation of the 
mean difference was 0.34 and the significance level was set at 0.05. It was decided 
that we should oversample by three subjects in the primary study to give a total 
sample of 20 subjects which would increase the power to 96%. 
The results of the power calculations used to establish the required sample size for 
the primary study are documented and further explained in the “Results” section of 
Chapter Four. 
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3.4  Discussion 
This pilot study provided two important contributions to this project and potentially 
the wider body of literature in which DOMS as an investigative tool in deep-tissue 
pain mechanisms is employed. 
Firstly, the reliability of NRS pain intensity scores (to an evoked stimulus) over the 
period of one hour was demonstrated. An ICC of 0.987 indicates very high reliability. 
This information was crucial to enable valid interpretation of our primary study 
results. 
On exploration of the literature regarding DOMS, it appears that there have been no 
previous studies investigating the within-session reliability of pain outcome 
measures. Many studies involving DOMS have investigated the effectiveness of 
certain treatment modalities on DOMS; for example the influence of vibration prior 
to exercise (Bakhtiary, Safovi-Farokhi, & Aminian-Far, 2007) or the effect of low-dose 
pulsed ultrasound administered daily post-exercise (Aytar et al., 2008; Howatson, 
Van Someren, & Hortobagyi, 2007). Many studies have been conducted as 
randomised controlled trials (RCTs) involving an intervention and a control group, 
with pain scores prior to the DOMS-inducing exercise session being compared to pain 
scores on consecutive days afterwards up to one week post-exercise. Pressure pain 
threshold at specified points along the muscle is a pain outcome measure assessed 
in some of these studies (Bakhtiary et al., 2007; Howatson et al., 2007; Olsen, 
Sjøhaug, van Beekvelt, & Mork, 2012) . Another outcome measure used regularly is 
the visual analogue scales that consists of a 100 mm line with “no soreness” at one 
end and “unbearably painful” at the other, or similar, to determine muscle soreness 
in response to mechanically-evoked pain. This could be in the form of a stretch on 
the muscle (Aytar et al., 2008; Howatson et al., 2007) or use of the sore muscle 
(Matsuda, Kan, Uematsu, Shibata, & Fujino, 2015). These outcome measures would 
have taken a minimum of a few minutes to assess or observe, and it has merely been 
assumed that the pain scores would have remained constant over that testing period. 
However this has never been proven. This pilot study has now provided this evidence, 
particularly for pain which is evoked mechanically as in this pilot study, which in turn 
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assists to validate the results of previous studies which have conducted their testing 
over a period of time lasting up to one hour. 
Some studies have used eccentric exercise-induced muscle soreness to investigate 
properties of a specific muscle group. In a study by Binderup, Arendt-Nielsen, and 
Madeleine (2010), the heterogeneity of the development of muscle hyperalgesia 
within the trapezius muscle was demonstrated by mapping the pressure-pain 
sensitivity throughout the muscle 24 hours after eccentric exercises were performed 
to induce muscle soreness. Fernández-Carnero et al. (2010) also mapped 
topographical pressure pain sensitivity. In this case it was around the lateral elbow of 
subjects who had exercise-induced lateral epicondylalgia in order to help establish 
and implicate the extensor carpi radialis brevis muscle belly in lateral epicondylagia. 
Whilst threshold values are conceptually separate from evoked pain responses, the 
high temporal stability of the pain scores established through this pilot study, add 
weight to conclusions drawn from studies involving topographical mapping of various 
properties of muscles affected by DOMS. 
 
To date, most studies investigating potential treatment modalities for DOMS have 
involved control and experimental groups as opposed to within-subject, repeated 
measures designs. Our study has demonstrated reliability of the within-session self-
reported pain outcomes, allowing for the use of this design in future repeated-
measure studies.  DOMS is already frequently used as an experimental form of pain 
and as research into pain evolves the use of DOMS is likely to escalate as an ethical, 
safe and effective form of experimental deep tissue pain. It is therefore imperative 
that this reliability has been established for both the currently used RCT designs as 
well as potential future repeated-measures within-subject designs. 
 
Secondly, the within-subject mean difference was calculated and used as the 
threshold for determining the minimal detectable change for the primary study.  This 
was established to be 0.3 on a NRS scale. This value was used to assist us in calculating 
the sample size required in the primary study. Furthermore it also provides a 
threshold value below which changes in NRS may be considered ‘noise’ or natural 
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variance between individuals but above which may be interpreted as representing 
actual change in scores. Prior to this study, the value of this was largely unknown or 
assumed information. 
 
3.5  Conclusion 
This pilot study succeeded in establishing the stability of the movement-evoked pain 
responses during DOMS perception over the course of one hour. This was imperative 
to ensure valid analysis of our primary study data. Furthermore, this contributes to 
previous research involving DOMS whereby temporal stability of mechanically-
evoked pain responses during DOMS has previously merely been assumed.  
Based on data from the pilot study we estimated a within-subject difference in means 
of 0.3 on the pain intensity NRS. This was used as the threshold for determining the 
minimal detectable change in the power calculation for the primary study. 
Furthermore, this figure could be used in future research as a quantifiable threshold 
value to assist in determining significant effect sizes. 
 
The sample size calculation for the primary study was based on a minimal detectable 
mean difference of 0.3 and on a standard deviation of the within-subject mean 
difference being 0.34. It was established that 17 subjects in the primary study to 
achieve 90% power (see section 4.2 for more detail on the sample size calculations). 
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CHAPTER FOUR: PRIMARY STUDY 
 
 
This study attempted to establish whether visualisation of the painful body part has 
an effect on experimental pain induced by stimulation of deep tissue, and if so, 
whether this was in the direction of analgesia.  Secondly, this study explored whether 
visual distortion of body size impacts pain perception, specifically magnification of 
the viewed body part. Exploration of deep tissue pain is necessary as most clinical 
pain is believed to be contributed to by noxious information from tissues deeper than 
the skin (Bove et al., 2005). Therefore the results of this study could potentially be 
more clinically relevant than the findings of studies involving experimental superficial 
pain, upon which our hypotheses were based. 
This study has made use of “direct” visualisation of the thigh. For both the condition 
involving normal vision of the thigh and the condition involving a magnified view of 
the thigh the subject will observe their thigh directly, albeit through magnifying 
glasses in the magnified condition. This avoids the use of the mirror box which is the 
mechanism that Torta et al. (2015) has proposed to be responsible for the visual 
analgesia described by Longo et al. (2009), eliminating this as a potential confounder. 
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4.1  Study Design and Methodology 
A repeated-measures within-subjects randomised experiment was carried out at The 
University of Notre Dame Australia, Fremantle.  This study received ethics approval 
from the HREC of The University of Notre Dame Australia (Reference number: 
014036F) and all participants provided written informed consent. 
Variances in eye sight meant that it was not possible to use a consistent strength of 
magnifying lens in the magnified condition as the view of the thigh would not be in 
focus for some of the subjects. The testing position and strength of magnifying 
glasses was therefore slightly variable between subjects. The strength of the 
magnifying glasses ranged from +1.5 to +3.5. The strongest magnification possible 
was used whilst still maintaining clear focus of the thigh. The process to establish the 
appropriate glasses strength and thigh position will be explained in detail in the 
“Establishing the testing position” section below.  
 
4.1.1 Participants.  
A cohort of 20 healthy individuals were recruited using a general email advert and a 
snowball sampling technique of the students and staff of The University of Notre 
Dame Australia. Due to the fact that some of the subjects were current students of 
the School of Physiotherapy, there was the possibility of bias being an issue. To 
mitigate this problem, the author ensured that none of the subjects were her current 
students, and each participant was clearly advised that they may withdraw at any 
stage of the study with no consequences.  
Inclusion criteria for the primary study were identical to those of the pilot: aged 
between 18 and 50 years, proficient in written and spoken English and the ability to 
provide informed written consent. Participants were excluded if they suffered 
ongoing lumbar spine problems, experienced abnormal tenderness to palpation of 
the soft tissues of the thigh, presented with reduced or excessive knee or hip 
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movement, had suffered leg pain that required a visit to a health care professional 
within the previous 12 months or had sustained a fracture or dislocation of the leg 
within the last five years. They were also excluded if they had any ongoing medical or 
neurological conditions, consumed regular anticoagulant medication or medications 
known to influence pain sensitivity (e.g. painkillers, anti-inflammatories, anti-
depressants) or if they had recently trained the quadriceps with eccentric strength 
exercises (within the previous six months). An exclusion criterion unique to the 
primary study was any participant who required glasses to obtain normal vision. The 
magnified condition in the primary study was established by fitting the subject with 
a pair of magnifying glasses. This would have been physically impossible to do if they 
were already wearing glasses. Wearing contact lenses at the time of testing was 
acceptable as long as the subject had normal vision with the lenses in situ. 
 
4.1.2 Experimental procedure.  
Each participant attended two sessions, 48 hours apart.  
 
Session one. 
The purpose of the first session was to obtain subject demographics, to establish a 
suitable test position for the 2nd session for each subject, to complete two 
questionnaires and to guide subjects through an exercise protocol aimed at inducing 
DOMS. 
On arrival, subjects received a Plain Language Statement, written informed consent 
was obtained and basic demographic information collected. The procedure of the 
study was explained to the subjects and they were asked to complete the short-form 
Pain Anxiety Symptoms Scale (PASS-20) questionnaire (see Appendix 1) and the Pain 
Sensitivity Questionnaire (PSQ) (see Appendix 2). The researchers felt it would be 
worthwhile to explore for any interaction between pain anxiety, trait sensitivity and 
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pain during the various visual conditions, hence the inclusion of these questionnaires. 
Thereafter the subject’s maximal isometric knee extension strength was assessed and 
the test position established in preparation for the 2nd session. Finally the subjects 
underwent the exercise protocol aimed at inducing DOMS.  
 
4.1.2i Maximal isometric knee extension strength. 
The assessor used a hand-held dynamometer to establish the maximum force each 
participant could generate with an isometric quadriceps contraction. This process 
was identical to that done in the pilot study- performed in a seated position, with the 
knee extended to 10⁰ off full extension. The subject was instructed to extend the 
knee maximally against the resistance of the dynamometer until the “beep” sound 
was heard. The maximum force generated during the contraction was recorded on 
the dynamometer and documented. This was repeated three times for consistency 
and the average score used to calculate the amount of resistance required during the 
testing session (see 4.1.3vii Testing procedure)  
 
4.1.2ii Establishment of testing position.  
During the first session the assessor sought to establish an appropriate test position 
and the maximal magnification strength which could be used during the testing 
process of the second session. Subjects were seated on a narrow desk, leaning back 
comfortably against a wall for back support. Each subject donned the strongest 
magnifying glasses (+3.5) and looked at their thigh to see if the thigh was in clear 
focus. If not, they flexed their hip bringing their knee up towards their head. They 
were instructed to stop at the point where the thigh came into focus. If the subject 
was unable to focus clearly on the thigh at any point through their comfortable range 
of hip flexion then the glasses with 0.5 less magnification strength was attempted 
next. The same procedure was repeated until the subject was able to find an 
appropriate pair of glasses and the exact position of their thigh to achieve clarity. 
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Once the correct magnifying strength and thigh position had been established the 
magnification strength and hip flexion angle was documented and used consistently 
for all four visual conditions in the testing session. The angle of hip flexion ranged 
between 90⁰ and 140⁰ between the subjects. 
 
4.1.2iii Exercise protocol to induce DOMS. 
The participant undertook exactly the same protocol as in the pilot study aimed at 
inducing DOMS in the non-dominant quadriceps muscle group. They were closely 
monitored and the movement was controlled by the researcher.  
 
4.1.2iv PASS-20. 
The PASS-20 consists of 20 items and measures fear and anxiety responses specific 
to pain. Subjects were asked to circle one number from 0 which represents “never” 
to 5 which represents “always” for each situation described. The total score out of 
100 was established by calculating the sum of all the items. This questionnaire took 
5-10 minutes to complete. 
 
4.1.2vi PSQ. 
The PSQ consists of 17 items. Each item describes a daily life situation and asks the 
subject to rate how painful this would be for them on a scale of 0 to 10. There are 
normally non-painful situations serving as sensory references interspersed between 
a variety of types of painful situations e.g. hot, sharp etc. The PSQ-total score was 
calculated as the average rating of items 1, 2, 3, 4, 6, 7, 8, 10, 11, 12, 14, 15, 16, and 
17 (all but the three non-painful items). This questionnaire took between 5-10 
minutes to complete. 
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Plain language statements sent by email to subject prior to first session 
↓ 
Arrival of subject at first session 
↓ 
Procedure of session explained verbally 
↓ 
Written consent obtained, demographics collected 
↓ 
PASS-20 and PSQ questionnaires completed 
↓ 
Maximum isometric quad strength at -10⁰ off full extension established 
↓ 
Strength of magnifying glasses and test position established and documented 
↓ 
Exercises completed 
Figure 5. Flow diagram to represent sequence of events at subjects’ first visit. 
 
Session two. 
The 2nd session was attended 48 hours after the 1st session. The purpose of the 2nd 
session was to determine the subject’s eligibility for continuation in the study, 
establish the randomisation order of exposure for that subject to the four visual 
conditions and then to perform the testing. Eligibility to participate was established 
with the subject completing a previously validated Likert scale of delayed onset 
muscle soreness.  
 
4.1.2vi Likert scale. 
At the 2nd session following the DOMS induction in session one, subjects completed 
a previously validated Likert scale of delayed onset muscle soreness that recorded 
 77 
 
their perception of soreness they were experiencing at that moment in time. They 
needed to score ≥ 3 and fulfil all other inclusion criteria to be included into the study 
(see Appendix 4 for full data Collection template).  
 
1 A light soreness in the muscle felt only when touched/ a vague 
ache 
2 A moderate soreness felt only when touched/ a slight persistent 
pain 
3 A light muscle soreness while walking up and down stairs 
4 A light muscle soreness when walking on a flat surface 
5 A moderate muscle soreness, stiffness or weakness while walking 
6 A severe muscle soreness, stiffness or weakness that limits my 
ability to move 
Figure 6. Modified Likert Scale of muscle soreness. 
(Andersen et al., 2008). 
 
4.1.2vii randomisation of exposure to visual conditions. 
Eligible subjects were assigned the next participant number and this was recorded on 
the data capture sheet. They were asked to open the particular sealed envelope 
which corresponded to the participant number they had been assigned. Inside was a 
letter: A, B, C or D which matched one of four particular sequences of order of 
exposure to the visual conditions. The letters had been randomly generated by 
computer using Excel software and the four sequences had been derived using a Latin 
Square design. Once the order of exposure to the visual conditions had been 
established the testing procedure began.  
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4.1.2viii Testing procedure: evoked pain during DOMS. 
Testing was performed at the 2nd session 48 hours after the 1st session. The testing 
involved the subject performing quadriceps contractions under load at 15 minute 
intervals, under various visual conditions and rating the pain evoked by these 
standardised contractions. This process was completed at the 15 minute mark, 30 
minute mark, 45 minute mark and 60 minute mark. 
The four visual conditions we investigated were: 
 Visualisation of the thigh without visual manipulation 
 Visualisation of the thigh with magnifying glasses  
 Visualisation of the contralateral thigh 
 Visualisation of a neutral object 
“Visualisation of the thigh without visual manipulation” involved the subject merely 
observing the mid-thigh of the affected leg, positioned in their pre-established testing 
position. A sandbag was fitted to the distal tibia at the start of the fixation period. 
The load of the sandbag was standardised by calculating 40% of the average force 
recorded during the maximal isometric contractions completed during session one, 
48 hours previously. This was attached to the distal tibia using a Velcro strap at the 
commencement of each fixation period and only removed at the start of the washout 
period. The same sandbag was used for each of the four conditions. 
 “Visualisation of the thigh with magnifying glasses” was the condition used to create 
the magnified image of the affected thigh. Again, subjects observed the mid-thigh of 
the affected leg, but this time they observed the thigh through magnifying glasses. 
On completion of the testing process during the magnified condition, subjects were 
asked to rate the degree of magnification they were experiencing while wearing the 
glasses using the “Scale of perceived enlargement”, prior to the sandbag being 
removed for the wash-out period.  
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“Visualisation of the contralateral thigh” involved the subjects observing the mid-
thigh of the unaffected limb while the subject was still set up in the testing position. 
The affected limb was hidden from view by a box that was fitted over it. The box was 
also covered by a towel to ensure no visualisation of the affected thigh. 
The final condition, “Visualisation of a neutral object”, made use of a box as the 
neutral object. A box was placed over the affected thigh to hide the view of the thigh. 
The limb was maintained in the identical set-up position and the sandbag was fitted 
to the distal tibia throughout the fixation and testing procedure as per the other three 
conditions. The subject was asked to focus on the box for that condition. 
The fixation period lasted five minutes and was aimed at allowing the subject to adapt 
to the new visual condition. Following this period, the subjects performed the 
quadriceps contractions against the load of the sandbag. The researcher passively 
extended the affected knee joint. From this position the subject was verbally guided 
to perform a controlled lowering of the foot towards the floor, allowing flexion of the 
knee toward 90° over the period of 3 seconds. This movement required an eccentric 
lengthening contraction of the DOMS-affected quadriceps muscle. This procedure 
was repeated three times and between each of the three repetitions the assessor 
extended the knee passively, returning it to the starting position of full knee 
extension. Pain was rated using an 11-point numerical rating scale (NRS) with 0 
reflecting no perceived pain and 10 reflecting the worst possible pain. Pain was rated 
by the participant immediately following each standard contraction. After three 
contractions the sandbag was removed and the subjects were given a five minute 
washout period. This process was repeated for all four visual conditions.  
If the subject rated their pain consistently as zero out of ten on the NRS, then the 
subject was excluded from the study. 
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a)        b)  
 
c)   d)  
 
Figure 7. The four visual conditions. 
This figure illustrates the four visual conditions we investigated; namely the effect of a) 
normal vision b) magnified condition c) vision of contralateral thigh d) vision of neutral object 
on the perceived level of pain. 
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4.1.3viii Scale of perceived enlargement. 
Varying strengths of magnifying glasses had to be used to accommodate for 
differences in people’s eyesight. Following the eccentric contractions performed with 
the magnifying glasses on, to ensure that visual manipulation of leg size by the glasses 
had been effective, the subjects estimated the effect of the glasses using a nine-point 
scale. The subjects were asked to rate the degree of magnification they perceived 
prior to removing the glasses, using the following scale:  
 
 
 
 
 -4           -3           -2          -1            0        1        2           3           4 
Extremely                Normal       Extremely 
shrunken                 size        enlarged 
 
 
Figure 8. Scale of Perceived Enlargement. 
This scale was used by the subjects during the magnified condition to estimate the effect of 
magnification induced by wearing the glasses. 
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Subject scored pain according to Modified Likert Scale (appendix 3) 
        ↓                                                                                  ↓ 
Score ≥ 3                                                                    Score < 3 
        ↓                                                                                  ↓ 
Included in study                                                   Excluded from study 
                             ↓                                                                                           
Participant number allocated 
                             ↓ 
Corresponding  sealed envelope  opened and sequence of visual conditions 
revealed 
                             ↓ 
Start of exposure to visual condition 
Sandbag strapped around distal tibia 
                             ↓ 
5′ fixation period to visual condition 
                             ↓ 
3 submaximal eccentric repetitions performed 
                             ↓ 
Subject scores each contraction /10 on NRS 
                             ↓ 
(Estimation of perceived magnification of thigh using 9-point scale for magnification 
condition only) 
                              ↓ 
Sandbag removed for washout period 
                              ↓ 
Process repeated  from Start of exposure to visual condition 
for next visual condition                          
 
Figure 9. Flow diagram to represent sequence of events at subjects’ second visit. 
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4.2  Data Analysis  
4.2.1 Sample size calculation. 
Based on data from the pilot study, the within-subject difference in means in pain 
intensity ratings (NRS) over the hour was estimated to be 0.3 and this was used as 
the threshold for determining the minimal detectable change in the power 
calculation for the primary study. The power of a four phase cross-over design using 
a minimal detectable difference of 0.3 achieved 90% power when a minimum of 17 
subjects were recruited, the standard deviation of the mean differences was 0.34 and 
the significance level was set at 0.05. We oversampled by three subjects in the 
primary study to give a total sample of 20 subjects which increased the power to 96%. 
 
This graph gives the sample size for three different values of the mean difference and the 
impact on Power (0.3, 0.4 and 0.5). A sample size of 20 retains a power of greater than 80% 
in all three cases. 
 
 
Figure 10. Graph to establish sample size required in Primary Study. 
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4.2.2 Exploration of the data and tests for normality. 
Descriptive statistics were used to present demographic data, pain ratings for each 
experimental condition and results from the PASS-20 and PSQ. Normality of 
distribution was assessed by visual inspection of Q-Q plots and further investigated 
with Shapiro-Wilk tests for normality. All results were reported as Mean ± SD. A p 
value of <.05 was considered to represent statistical significance. All data were 
analysed using IBM SPSS Statistics 23.0 software. 
 
4.2.3 Methodological checks. 
 
4.2.3i Effectiveness of the glasses used to magnify the image of the thigh. 
Descriptive statistics were used to report the results of the nine-point scale to 
establish the effectiveness of the glasses used to produce an enlarged image of the 
affected thigh during the “magnified” condition. A score of 0 would indicate that the 
thigh is perceived as being the same size as normal, with increasing positive scores 
indicating increasing degrees of perceived enlargement. 
 
4.2.3ii Exploration of potential confounding variables. 
 
The effects of co-variates on the primary dependent variable were analysed using a 
general linear model (repeated measures) with the relevant covariate included.  Age, 
trait pain sensitivity (PSQ) and trait pain anxiety (PASS-20) were treated as covariates 
within the model whilst gender and order effect were treated as between-subject 
factors.  
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4.2.4 Hypothesis testing. 
 
4.2.4i Effects of vision on pain perception. 
 
A general linear model (repeated measures) was used to test the primary hypotheses. 
Pain intensity rating was the dependent variable and the visual condition was the 
independent variable with four levels (neutral object, visualisation of contralateral 
thigh, normal visualisation of thigh, magnified visualisation of thigh). Covariates and 
between-subject factors found to be statistically significant were adjusted for in the 
overall general linear model test. 
 
4.3 Results 
4.3.1 Exploration of the data and tests for normality. 
A total of 22 subjects were recruited from staff and students at The University of 
Notre Dame Australia.  One participant was excluded at the start on the first session 
as he did not meet the inclusion criteria (he was taking regular analgesia for cervical 
spine-related pain). A second was excluded at the end of the second session as he 
recorded no pain with any eccentric contraction during any of the experimental 
conditions. Twenty participants met all inclusion criteria and were included in the 
analyses. All participants completed all experimental conditions and there were no 
missing data. 
Of the 20 participants 8 were male and 12 female. The average age was 26.45 years 
± 7.0 with a range from 20 to 47 years. The average PSQ score was 2.58 ± 0.76. This 
score would be classified as a low trait sensitivity score (Kim et al., 2015). The average 
PASS-20 scores for our study was 17 ± 15.14. Again, this would be classified as a low 
pain-related anxiety score (Abrams, Carleton, & Asmundson, 2007).  
At the start of the second session the average score on the Modified Likert scale 
representing pain intensity during the previous 24 hours was 3.9 ± 0.54, with a range 
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of 3 (the minimum entry criteria) to 5. This meant that every participant was eligible 
to continue with the testing procedure and could be included in the study. 
Shapiro-Wilks tests for normality demonstrated the majority of the data was not 
normally distributed and there were several outliers across three out of the four 
conditions. In order to meet the assumptions behind the general linear model 
(repeated measures) the data were log-transformed. All further analysis of the 
primary dependent variable was performed on this new log-transformed data. Log-
transformation resulted in the majority of the data being normally distributed 
(Shapiro-Wilks test p >0.05) and a significant loss of outliers (only one outlier for one 
condition). 
 
4.3.2 Methodological Checks. 
4.3.2i Effectiveness of the glasses used to magnify the image of the thigh. 
 
The average “Effect of Magnification” questionnaire score was 1.8 ± 0.6, with a 
minimum value of 1.0 and a maximum value of 3.0, indicating the glasses to be 
effective in producing an enlarged image of the thigh. A score of 0 would indicate 
that the thigh is perceived as being the same size as normal, with increasing positive 
scores indicating increasing degrees of perceived enlargement.  
 
4.3.2ii Exploration of potential confounding variables. 
 
Age, PSQ and PASS-20 were individually included as covariates in the general linear 
model (repeated measures). All analysis demonstrated that assumptions of sphericity 
were met. There was no significant interaction between the condition and age, 
(F=.357(3,54), p=.784). Analysis of PSQ and condition demonstrated no interaction 
(F=1.596 (3,54), p=.201). Lastly, PASS-20 and condition similarly demonstrated no 
interaction (F=1.331 (3,54), p=.274). 
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Gender and order effect were explored as between-subject factors in the general 
linear model (repeated measures). There was no interaction between gender and 
condition (F=0.098 (3,54), p=.961). A main effect for order by condition was found 
(F=2.111 (9,48), p=.047) however post-hoc pair-wise comparisons were not statistically 
significant (p>0.05 for all comparisons).  
 
 
4.3.3 Hypothesis testing. 
4.3.3i Effect of vision on pain perception. 
 
The mean pain intensity reported under each of the visual conditions can be found in 
Table 2. To determine if pain intensity varied between the visual conditions a general 
linear model (repeated measures) on the log-transformed data across all four visual 
conditions was used. As there was no evidence of an interaction between order, age, 
gender, PASS-20 or PSQ and condition, treatment effects were estimated unadjusted 
for these factors. A significant main effect of visual condition on pain score (NRS) was 
found (F=2.797 (3,57), p=.048). However Bonferroni corrected post-hoc pairwise 
comparisons demonstrated no significant difference between any conditions, 
indicating that pain intensity was not significantly influenced by visual condition. We 
therefore accept the null hypothesis that vision and visual distortion of size in the 
form of magnification have no significant effect on the intensity of perceived 
experimental deep tissue pain. 
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Condition Mean ± SD 
Neutral object 2.68 ± 1.16 
Contralateral thigh 2.73 ± 1.48 
Normal vision of thigh 2.60 ± 1.65 
Magnified view of thigh 3.05 ± 1.57 
Table 2. Mean and Standard Deviations of NRS pain scores across the four conditions. 
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4.4 Discussion 
4.4.1 Summary of main findings. 
The aim of this project was to examine whether visualisation of the painful body part 
has an effect on experimental deep tissue pain in a healthy population. Secondly, we 
set out to determine if visual distortion of size, in the form of magnification, had a 
further effect on the perceived pain.  
Recent studies investigating visual analgesia in response to observation of a 
superficial noxious stimulus led to the first hypothesis: that visualisation of the 
painful body part could influence deep tissue pain. Since results of these studies have 
been mixed the direction of the effect could not be predicted with confidence. 
Studies investigating the effect of visual distortion of size on perceived pain in both 
clinical and non-clinical populations have also reported contrasting results. Our study 
aimed to establish the effect of magnification of the painful viewed body part on deep 
tissue pain in a healthy population. We hypothesised that visual magnification would 
produce an effect on the intensity of perceived pain, again without being able to 
predict the direction of the effect. 
Contrary to our first hypothesis we found that direct visualisation of the painful body 
part, which in this case was the anterior thigh, had no significant effect on pain 
intensity ratings of experimental deep tissue pain. Furthermore, visual distortion of 
size in the form of magnification had no significant effect on perceived pain levels in 
a healthy population.  
When we explored for potential confounding variables, the covariates of age, pain 
sensitivity and trait anxiety did not demonstrate any significant interactions with the 
visual conditions and neither did gender and order effect when explored as between-
subject factors. 
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4.4.2 Relationship to existing literature. 
This is a novel study. There are no similar studies against which our study can be 
directly compared since no previous studies have investigated the effects of vision 
and visual distortion of size on experimental, deep tissue pain. Our hypotheses were 
based on the findings of experiments involving noxious stimuli applied cutaneously 
to induce experimental, superficial pain in healthy subjects and on studies involving 
clinical populations. Significant differences appear to exist between the underlying 
mechanisms and the presentation of superficial and deep pain. With this in mind, we 
anticipated but could not confidently predict a visual analgesic effect on deep tissue 
pain. In our study vision had no effect on perceived pain.   
Our findings contradict those of Longo et al. (2009), who demonstrated an analgesic 
effect of visualisation on superficially-induced experimental pain in a healthy 
population. Although both studies involved experimental pain, a major difference 
between the two studies is that our study involved noxious stimulation of deep tissue 
while that of Longo et al. (2009) involved superficial stimulation. It is possible that the 
analgesic effect to visualisation observed when the cutaneous tissues were 
stimulated is optimised as the tissues being stimulated are directly observable and 
visualisation could reduce the threat value of the pain by providing the individual with 
information that all is well with the stimulated tissue. This is in contrast to deep tissue 
stimulation where only the overlying skin can be observed however the actual tissue 
affected cannot be visualised directly so adding visual input would not have 
significant informative value in terms of perception of safety of the stimulated 
structure. A further important difference is the different method of visualisation 
employed in the two studies. It has been proposed that the visual analgesic effects 
observed in the experiment by Longo et al. (2009) may be more as a result of viewing 
a reflected image than due to the effects of vision (Torta et al., 2015).   Torta et al. 
(2015) investigated their proposal by comparing pain intensity ratings of superficial 
noxious stimuli with subjects observing their hand directly, an illusion of their hand 
via the use of a mirror-box and a neutral object. There were no significant differences 
noted across the different conditions and no visual analgesia was observed under any 
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of the conditions. Our findings would tend to support those of Torta et al. (2015)  as 
our study excluded the use of a mirror box and no effect was observed.  
Our findings also support some of the observations of Valentini et al. (2015), who did 
not observe a visual  analgesic effect when the hand was situated on the normal side 
of the body. They only found visual analgesia of experimental, superficial pain to exist 
when the limb was placed on the contralateral side of the midline. In our current 
study, we did not explore the effects of vision coupled with crossing the midline on 
deep tissue pain, but our results concur in that we did not observe visual analgesia 
when the limb was observed in its regular ipsilateral position.  
When we compare our study to those which investigate the effects of vision in clinical 
populations, our results differ. Both Wand et al. (2012) and Diers et al. (2015) 
observed analgesic effects with vision of the back in chronic back pain sufferers. 
Wand et al. (2012) made use of a mirror to allow subjects to view their backs, while 
Diers et al. (2015)   used real-time video feedback. Perhaps the mechanism driving 
the effects observed in both these experiments was similar to that underlying the 
observations in the experiments which used a mirror-box (that of possible conflict 
between the somatosensory, visual and proprioceptive representations requiring 
higher cognitive processing levels with resultant pain inhibition). Our study made use 
of direct visualisation i.e. no reflected images were generated and no analgesic effect 
was observed.  An alternative and very plausible explanation for the positive findings 
in response to visualisation may be due to the particular part of the body which is 
involved. In both these studies the part visualised i.e. the back, is a region of the body 
which is not readily visible to the subject. It was evident that the introduction of visual 
feedback from the back region made a significant difference to the perceived pain 
intensity. In our study, the affected body part is body part that is usually visible to the 
subject so the novelty and additional information provided by visualisation would 
have been minimal. 
With regards to our second hypothesis proposing that visual magnification of a 
painful body part would induce an effect on pain, the results of this study differ from 
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Mancini et al. (2011) upon which the hypothesis was formulated. Our study found no 
significant effect of the visual magnification condition although  Mancini et al. (2011) 
did note an analgesic effect. A major difference between the two studies is that  
Mancini et al. (2011) employed a topical noxious stimulus which induced superficial 
pain, while our study  involved deep tissue stimulation. The linear relationship 
between pain perception and visual magnification that was demonstrated by Mancini 
et al. (2011) was less consistently demonstrated by Osumi et al. (2014) in that only 
the subjects who displayed more vivid tactile perception demonstrated an increase 
in pain thresholds to the magnified condition (the “high” threshold group). The “low” 
threshold group, demonstrating a lower pain threshold, displayed a negative 
emotional response to the enlarged view and no TPD change. Again, the pain induced 
in this experiment was perceived superficially. These findings contrast those in our 
present study where no analgesia nor any effect of magnification was observed. 
Mancini et al. (2011) and Osumi et al. (2014) both made use of mirror-boxes to 
enlarge the view of the limb and this variance in methodology could be a contributing 
factor to the different results obtained between the studies, as has been suggested 
by Torta et al. (2015). An alternative explanation is that superficial pain mechanisms 
vary from deep pain mechanisms and that researchers and clinicians should avoid 
extending the results of studies involving superficial experimental pain to 
experimental deep pain or clinical pain presentations (S. Mense, 2003; Uematsu et 
al., 2011; Witting et al., 2000). The question remains whether findings of studies such 
as ours (involving experimental deep tissue pain) can be generalised to clinical 
chronic pain presentations. 
Moseley et al. (2008) found a significant effect of visual distortion of size in a CRPS 
population. Minification and magnification using binoculars reduced and augmented 
the pain respectively. The findings of Ramachandran et al. (2009) tend to support this 
in a phantom limb pain population. Visual analgesia was demonstrated using a 
mirror-box, and although no effect was observed in the magnified condition, there 
was a significant analgesic effect with minification. These findings contrast the results 
of the experiments by Mancini et al. (2011) and ourselves.  This may highlight the 
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difference between experimental and clinical pain presentations but it could also 
exist because CRPS and phantom limb pain are unique and extreme chronic pain 
experiences in which the visual appearance of the painful area is greatly disrupted 
(Birklein, Riedl, Claus, & Neundörfer, 1998; Harden et al., 1999) and visual 
manipulation, particularly in the form of normalisation,  is likely to have a powerful 
threat-reducing effect.   
The PASS-20 is a brief version of the original PASS-40 and has been shown to be a 
good reflection of the PASS-40 (Roelofs et al., 2004). Both these measures assess four 
distinct components of pain anxiety: cognitive anxiety (catastrophic thinking), fearful 
thinking about pain and anticipated negative consequences related to pain, escape 
and avoidance behaviour, and physiological anxiety (heightened arousal) (Watt, 
Stewart, Moon, & Terry, 2010). If desired, subscale scores for these components can 
be determined by summing particular items in the questionnaire together for each 
component of pain anxiety. In this study we were more interested in a general pain 
anxiety score so we used the total scores for our analyses. During the “neutral object” 
visual condition of the present study, the subject’s view of their painful thigh was 
obstructed by the box. This could have potentially reduced the level of perceived 
control the subject had over their painful body part and induced a measure of 
subsequent fear or heightened anticipation of pain (one of the components of pain 
anxiety). Pain anxiety has been found to be associated with augmented pain 
perception (L. M. McCracken & Gross, 1998) however our results did not 
demonstrate a significant interaction between the PASS-20 scores and the pain 
scores during the “neutral object” visual condition. In previous studies, the majority 
of individuals classified as having “high” pain-related anxiety have been shown to 
have PASS-20 total scores greater than 30 (Abrams et al., 2007). The average PASS-
20 scores for our study was 17 ± 15.14, which is well below that threshold. It should 
be noted, however, that the population involved in this experiment was a collection 
of physiotherapy students who had received education in the mechanisms underlying 
pain perception, and thus were likely to present with relatively lower pain anxiety 
levels than the general public. 
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When we explored for possible interactions between trait pain sensitivity (reflected 
by the PSQ questionnaire) and the reported pain scores during the various visual 
conditions no significance was apparent. There have been significant correlations 
reported between PSQ scores and experimental pain intensity ratings in healthy 
subjects (Ruscheweyh et al., 2009). PSQ scores have also been reported to be 
significantly associated with pain anxiety and fear scores (Nelson & Massey, 2013). 
With no significant pain intensity ratings being observed across any of the visual 
conditions in the current study, and no interactions demonstrated between trait 
anxiety and pain scores, we did not expect to observe a significant finding between 
the pain sensitivity and the pain scores across any of the visual conditions either. Our 
results confirmed our expectations. 
 
4.4.3 Clinical implications and contributions. 
This thesis makes an original contribution to knowledge as no previous studies have 
investigated the modulatory effects of visualisation or visual magnification on deep, 
experimental pain. These effects have previously been explored in experimental 
superficial pain and clinical populations although it has remained unclear whether we 
could extrapolate the results of previous studies to acute deep tissue pain. Previous 
studies have also yielded contrasting effects making it difficult to predict with 
confidence the direction of the effects on deep tissue pain. As highlighted in the 
previous section (section 4.4.2) various hypotheses could explain the results of each 
of those studies. Combining the findings of previous research and those in our study 
some common themes start to evolve which appear to be able to consistently explain 
the various findings. 
Clinical populations in which visualisation and visual distortion of size have had an 
effect appear to be those in which the condition involves significant visible physical 
changes to the affected area.  In a CRPS population, such as that researched by 
Moseley et al. (2008), changes in the subjects’ hair and nail growth can be seen, as 
well as swelling, excessive sweating or dry skin. In a phantom limb pain patient such 
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as that studied by  Ramachandran et al. (2009), there is a significant visual change 
with the absence of a limb. The introduction of visual feedback would have allowed 
subjects to normalise the perceived appearance of their limb and this is likely to have 
reduced fear associated with the pain contributing to the analgesic effects observed. 
Our study involved experimental pain in the form of DOMS. DOMS is likely to have 
been experienced regularly by our cohort of healthy subjects in the past. Ethically, 
we were obliged to disclose that the type of pain induced was merely a transient pain. 
These factors would have contributed to the lack of threat associated with the DOMS 
pain inflicted on them. Furthermore there were no physical changes or observable 
abnormalities associated with the pain induced in the subjects, so the impact of visual 
input would have been minimal compared to the visual input which normalised the 
CRPS or phantom limb subjects’ perception of their limb appearance. This would help 
to explain our negative findings.  
It appears that visual analgesia also depends on the body part affected. If a body part 
is usually not visible to the subject then visual feedback is likely to have a greater 
impact than visualisation of a body part that is usually readily visible.  Supporting this 
proposal, would be the findings of Wand et al. (2012) and Diers et al. (2015) who 
demonstrated analgesic responses in chronic back pain patients with the subject’s 
visualisation of their backs. Although there may not be visible changes to the 
appearance of the back, the back is a region of the body which is not readily visible 
to the subject and the introduction of visual feedback from this region is likely to have 
provided participants with information about the state of their back that is not 
normally accessible to them. Our study indirectly supports this notion too. We can 
usually see our anterior thigh easily so adding visual feedback doesn’t add 
information or reduce the threat value of the perceived pain. 
That Longo et al. (2009) and Mancini et al. (2011) observed analgesic effects of 
visualisation and visual distortion of size respectively, of readily observable body 
parts such as the hand, may be explained by the fact that the pain induced in their 
studies was topical. Visualisation would have enhanced the subjects’ sense of safety 
by relieving any fears of injury resulting from the perceived noxious stimulus, and in 
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turn inducing an analgesic effect. This proposal would also explain the lack of effect 
observed in our present study. The pain induced was deep tissue pain. The tissues 
affected were not directly observable so there was not the same sense of safety and 
control to be gained as there was by observing topical pain. Furthermore, research 
suggests that the nature and underlying mechanisms of topical pain and deep tissue 
pain differ significantly (S. Mense, 2003; Uematsu et al., 2011; Witting et al., 2000). 
As a result one should not automatically expect a common modulatory phenomenon 
to exist for both types of pain.  
The main aim of this study was to explore the mechanisms underlying deep 
experimental pain. The priority was not to source new treatment options, although 
favourable findings to visualisation or visual magnification may have informed future 
treatment. From a clinical perspective, it appears that “direct” visualisation and 
“direct” visual magnification may not be useful for acute pain management programs 
in the case of pain perceived in body parts that are readily observable. Visualisation 
is more likely to have a greater impact on body parts which cannot usually be seen 
such as the lower back. This hypothesis would be supported by the results observed 
by Wand et al. (2012) and Diers et al. (2015). The likely mechanism underlying this 
analgesia is the “de-threatening” effect that visual input would have on a body part 
that cannot usually be seen. Also, from a clinical perspective, visual analgesia is likely 
only to exist for pain which associated with altered body perception or physical 
changes to the appearance of that body part, as observed by Ramachandran et al. 
(2009), Moseley et al. (2008) and Preston and Newport (2011). All these studies 
manipulated the visual feedback serving to normalise the perception of that body 
part and in so doing maybe increase the sense of safety and provide evidence that all 
is well with that body part and consequently modulate the pain experience. 
Visualisation is unlikely to have any impact on pain whereby the overall appearance 
of the body part remains normal. This notion is supported by the results of Torta et 
al. (2015) and by our study.  
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CHAPTER FIVE: LIMITATIONS, RECOMMENDATIONS AND 
CONCLUSION 
 
 
5.1  Limitations  
Ethically, there is a limitation to the amount of pain that can be inflicted on or induced 
in subjects, and by the ways in which this pain can be induced. A widely used means 
of inducing transient, endogenous experimental pain is via the DOMS phenomenon. 
It induces an acceptable level of pain, although the pain level may be below those 
pain levels experienced by the clinical population, especially those with chronic pain. 
Also, the pain induced is experimental. Ideally, studying a clinical population would 
be more relevant but it is very difficult to standardise subjects and testing procedures 
as clinical pain states vary significantly from one individual to the next. The necessary 
constraints to ensure internal validity of the research would limit sample size. These 
limitations led to the decision to induce DOMS to represent deep tissue pain. 
Recognising that we cannot completely apply the results to clinical pain, the study 
does serve to give us a better understanding of the behaviour and mechanisms 
underlying deep tissue pain, which may be beneficial.  
 
One should consider the type of pain that was induced, the effect that our belief 
systems have on our pain perception and the potential effect this could have on visual 
analgesia. The majority of the population recruited for this study were physiotherapy 
students. These subjects are likely to have a greater interest in physical activity and 
hence have been exposed to DOMS of the lower limbs more frequently than a regular 
population. This frequent exposure to DOMS is likely to have reduced any pain-
associated fear. Through their curriculum the students are likely to have developed a 
comprehensive understanding of pain mechanisms. Understanding their pain would 
further minimise their fear.  It is probable that a reduction of the fear/ threat value 
associated with the pain would reduce perceived pain levels. It was imperative, 
therefore, to include the modified Likert scale to ensure that the subjects were 
experiencing adequate pain levels prior to the testing procedure. 
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5.2  Recommendations 
“Direct” visualisation alone did not influence pain rating in our study, however 
several studies involving experimental superficial pain (Longo et al., 2009; Mancini et 
al., 2011; Osumi et al., 2014) and those involving clinical pain populations (Moseley 
et al., 2008; Ramachandran et al., 2009) have noted visual analgesic effects using  
“indirect visualisation” (albeit in opposing directions). Use of a mirror-box has 
allowed this “indirect visualisation”. With this in mind, it may be worthwhile exploring 
whether a mirror-box has any effect on deep tissue pain. Researchers would need to 
be mindful that if DOMS is to be used as the experimental deep tissue pain, a muscle 
group needs to be chosen that is both easily visible by the subject (for example, the 
gastrocnemius is difficult to observe due to its dorsal location) and easy to situate 
alongside a mirror to induce an illusion. If an effect is noted while using the mirror 
box, it could be likely that the mechanism underlying this effect involves the 
introduction of a degree of conflict between visual, sensory and proprioceptive 
representations which requires augmented cognition to decipher, in turn affecting 
and inhibiting perceived pain levels. Depending on the direction of the effect, the 
mirror box could potentially be incorporated as a useful clinical tool for managing 
clinical pain.   
Our study was initiated prior to the publication of findings of Valentini et al. (2015) 
and Osumi et al. (2014), who  have not been able to reproduce the consistent visual 
analgesic results observed by Longo et al. (2009) and  Mancini et al. (2011). Valentini 
et al. (2015) did not use a mirror-box and could only get an analgesic effect with vision 
of the body part when it was combined with the affected limb crossing the midline. 
Taking this into account, it may also be worthwhile to include a “crossed midline 
condition” as another visual condition to the experiment suggested above.  
To explore visual analgesia in experimental, deep tissue pain, another study involving 
the use of real-time video feedback to produce an image of the affected body part, 
would be informative. Real-time video feedback has successfully induced visual 
analgesia in clinical populations studied by Diers et al. (2015) and Preston and 
Newport (2011). It has the potential to be a very practical treatment modality. It 
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could be used on all parts of the body (unlike the mirror- box) and would not involve 
the subjects crossing the midline (which is difficult to achieve with some body parts). 
The image could also be easily manipulated to increase or decrease the size of the 
viewed body part in order to normalise the subjects’ perception of their limb size if 
these are found to be helpful.  
Combining the findings of our current studies and other relevant research it is 
apparent that visualisation may only have a modulatory effect on pain when visual 
feedback offers a significant contribution to the generation or maintenance of 
perceived pain; in pain associated with visible changes to the affected tissues (or 
perceived to have physical changes in appearance), pain perceived in tissues which 
are directly visible (such as the skin as opposed to deeper tissues) or pain perceived 
in body parts that are not readily visible (such as the lumbar spine). With this in mind, 
it would be worthwhile inducing experimental deep tissue pain in healthy volunteers 
in a body part that is not readily visible, such as the back, buttock or hamstring 
regions, and exploring the effects of visualisation on the perceived pain intensity, in 
order to substantiate the proposal that visualisation has a modulatory effect only 
when the visual input, or lack thereof, plays a significant role in the generation or 
maintenance of pain.  
It would be also be worthwhile observing the effects of visual manipulation in a 
population of chronic pain sufferers involving body parts that are readily visible and 
that do not involve noticeable physical changes to the body part, but are perceived 
to have physical changes in appearance, that is the subject has a dysfunctional 
cortical representation of that body part. It would be interesting to establish whether 
normalising their perception via visual feedback has an impact on pain. Subsequent 
to the writing of this literature review a recent and relevant study has been published. 
Healthy subjects demonstrated physiological changes in the form of skin conductance 
response (SCR) to topical painful stimuli with the simultaneous use of embodied 
virtual images of the affected body part. SCR is reflective of the autonomic nervous 
system’s response to painful stimuli. Typically, stronger responses of SCR are 
observed for stimuli that are processed by the brain as more painful. The size of the 
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embodied virtual image was manipulated and the changes in SCR were found to be 
inversely proportional to the size of the image, as long as the image was believed to 
be the subject’s own body. Besides affecting pain processing and subsequently the 
SCR, the embodied virtual image did not result in any changes to the conscious 
experience of pain, that is the pain intensity rating of this superficial, experimental 
pain (Romano, Llobera, & Blanke, 2016). It may be worthwhile repeating a similar 
experiment of virtual embodiment but this time with a population of chronic pain 
sufferers in which the cortical representation of their affected part has been altered. 
Virtual embodiment would be easier to implement than the traditional mirror-box 
and the images could be easily manipulated to help normalise the subject’s 
perception of their affected body part. 
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5.3  Conclusion 
The aim of the present experiment was to investigate, firstly, whether visualisation 
of the painful body part has an effect on acute deep tissue pain in a healthy 
population, and secondly, to determine if visual distortion of size, in the form of 
magnification, has a further effect on the perceived pain, and if so, whether this is in 
the direction of analgesia. 
We found that visualisation of the painful body part had no significant effect on pain 
intensity ratings of experimental deep tissue pain. Furthermore, there was no 
significant effect of visual magnification on perceived pain levels.  
The findings of this study have highlighted that experimental superficial, 
experimental deep and chronic pain mechanisms appear to have different 
modulatory factors. The results of our study together with the studies explored in 
this literature review suggest that effects of visualisation and visual distortion of size 
are likely to be limited to specific circumstances; when there are significant visual 
changes to the appearance of a body part associated with the perceived pain or when 
the pain is perceived in a body part that is not usually observed so visual feedback 
has a major impact. We suggest that the augmented sense of safety and control that 
visualisation introduces to topical pain explains the analgesic effect, contrasting the 
lack of effect noted in our study involving “unobservable” deep tissue pain. 
This study has contributed to a better understanding of the effects of visualisation as 
a modulatory factor in acute deep tissue pain, however it is important to note that 
only “direct” vision and “direct” visual magnification of the painful limb were tested 
against control conditions. Conditions coupling visualisation with the use of a mirror 
box, real-time video or subjects’ limbs crossing the midline were not explored. 
Subsequent to the data collection for this study, it has become evident that these 
factors could potentially contribute to visual analgesia. Further studies to investigate 
the effects of these conditions coupled with visualisation or visual distortion of size 
on deep tissue pain are warranted, as well as studies to explore the effects of 
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visualisation on experimental deep tissue pain in body parts that are not readily 
visible or clinical pain in which there is an altered cortical representation of that body 
part.   
Finally, as a result of this study, we can state with some confidence that acute deep 
tissue pain appears not to be affected by “direct” visualisation or “direct” visual 
magnification of the overlying skin of a body part which is usually readily observable. 
We further recommend that it is not worthwhile including this in a management plan 
for painful conditions of these regions. 
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Appendix 1: PASS – 20  
(Lance M. McCracken & Dhingra, 2002) 
Individuals who experience pain develop different ways to respond to that pain. We 
would like to know what you do and what you think about when in pain. Please use 
the rating scale below to indicate how often you engage in each of the following 
thoughts or activities. 
Circle one number from 0 (NEVER) to 5 (ALWAYS) for each item. 
 
1. I think that if my pain gets too severe, it will never decrease.     
  0 1 2 3 4 5 
2. When I feel pain, I am afraid that something terrible will happen.    
  0 1 2 3 4 5 
3. I go immediately to bed when I feel severe pain.      
  0 1 2 3 4 5 
4. I begin trembling when engaged in activity that increases pain.    
  0 1 2 3 4 5 
5. I can’t think straight when I am in pain.       
  0 1 2 3 4 5 
6. I will stop any activity as soon as I sense pain coming on.     
  0 1 2 3 4 5 
7. Pain seems to cause my heart to pound or race.      
  0 1 2 3 4 5 
8. As soon as pain comes on, I take medication to reduce it.     
  0 1 2 3 4 5 
9. When I feel pain, I think that I may be seriously ill.      
  0 1 2 3 4 5 
10. During painful episodes, it is difficult for me to think of anything else besides the pain.
  0 1 2 3 4 5 
11. I avoid important activities when I hurt.       
  0 1 2 3 4 5 
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12. When I sense pain I feel dizzy or faint.       
  0 1 2 3 4 5 
13. Pain sensations are terrifying.        
  0 1 2 3 4 5 
14. When I hurt I think about the pain constantly.      
  0 1 2 3 4 5 
15. Pain makes me nauseous (feel sick to my stomach).      
  0 1 2 3 4 5 
16. When pain comes on strong I think I might become paralysed or more disabled.  
  0 1 2 3 4 5 
17. I find it hard to concentrate when I hurt   .    
  0 1 2 3 4 5 
18. I find it difficult to calm my body down after periods of pain.    
  0 1 2 3 4 5 
19. I worry when I am in pain.         
  0 1 2 3 4 5 
20. I try to avoid activities that cause pain.       
  0 1 2 3 4 5 
 
Thank you for completing this questionnaire. 
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Appendix 2: Pain Sensitivity Questionnaire  
(Sellers, Ruscheweyh, Kelley, Ness, & Vetter, 2013) 
This questionnaire contains a series of questions in which you should imagine 
yourself in certain situations. You should then decide if these situations would be 
painful for you and if yes, how painful they would be. 
Let 0 stand for no pain; 1 is an only just noticeable pain and 10 the most severe pain 
that you can imagine or consider possible. 
Please mark the scale with a cross on the number that is most true for you. Keep in 
mind that there are no ‘‘right” or ‘‘wrong” answers; only your personal assessment 
of the situation counts. Please try as much as possible not to allow your fear or 
aversion of the imagined situations affect your assessment of painfulness.  
 
1. Imagine you bump your shin badly on a hard edge, for example, on the edge of a glass 
coffee table. 
How painful would that be for you? 
 
0 1 2 3 4 5 6 7 8 9 10 
not at all painful     most severe pain imaginable 
 
2. Imagine you burn your tongue on a very hot drink. How painful would that be for you? 
 
 
0 1 2 3 4 5 6 7 8 9 10 
not at all painful     most severe pain imaginable 
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3. Imagine your muscles are slightly sore as the result of physical activity. How painful would 
that be for you? 
 
 
0 1 2 3 4 5 6 7 8 9 10 
not at all painful     most severe pain imaginable 
 
4. Imagine you trap your finger in a drawer. How painful would that be for you? 
 
0 1 2 3 4 5 6 7 8 9 10 
not at all painful     most severe pain imaginable 
 
5. Imagine you take a shower with lukewarm water. How painful would that be for you? 
 
 
0 1 2 3 4 5 6 7 8 9 10 
not at all painful     most severe pain imaginable 
 
6. Imagine you have mild sunburn on your shoulders. How painful would that be for you? 
 
 
0 1 2 3 4 5 6 7 8 9 10 
not at all painful     most severe pain imaginable 
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7. Imagine you grazed your knee falling off your bicycle. How painful would that be for you? 
 
 
0 1 2 3 4 5 6 7 8 9 10 
not at all painful     most severe pain imaginable 
 
8. Imagine you accidentally bite your tongue or cheek badly while eating. How painful would 
that be for you? 
 
0 1 2 3 4 5 6 7 8 9 10 
not at all painful     most severe pain imaginable 
 
9. Imagine walking across a cool tiled floor with bare feet. How painful would that be for you? 
 
0 1 2 3 4 5 6 7 8 9 10 
not at all painful     most severe pain imaginable 
 
10. Imagine you have a minor cut on your finger and inadvertently get lemon juice in the 
wound. 
 
0 1 2 3 4 5 6 7 8 9 10 
not at all painful     most severe pain imaginable 
  
 108 
 
11. Imagine you prick your fingertip on the thorn of a rose. How painful would that be for 
you? 
 
0 1 2 3 4 5 6 7 8 9 10 
not at all painful     most severe pain imaginable 
 
12. Imagine you stick your bare hands into an esky filled with icy water for a couple of 
minutes. How painful would that be for you? 
 
 
0 1 2 3 4 5 6 7 8 9 10 
not at all painful     most severe pain imaginable 
 
13. Imagine you shake hands with someone who has a normal grip. How painful would that 
be for you? 
 
0 1 2 3 4 5 6 7 8 9 10 
not at all painful     most severe pain imaginable 
 
14. Imagine you shake hands with someone who has a very strong grip. How painful would 
that be for you? 
 
 
0 1 2 3 4 5 6 7 8 9 10 
not at all painful     most severe pain imaginable 
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15. Imagine you pick up a hot pot by inadvertently grabbing its equally hot handles. How 
painful would that be for you? 
 
0 1 2 3 4 5 6 7 8 9 10 
not at all painful     most severe pain imaginable 
 
16. Imagine you are wearing sandals and someone with heavy boots steps on your foot. How 
painful would that be for you? 
 
0 1 2 3 4 5 6 7 8 9 10 
not at all painful     most severe pain imaginable 
 
 
17. Imagine you bump your elbow on the edge of a table 
 (‘‘funny bone”). How painful would that be for you? 
 
0 1 2 3 4 5 6 7 8 9 10 
not at all painful     most severe pain imaginable 
 
18. Imagine you pick up a hot pot by inadvertently grabbing its equally hot handles. How 
painful would that be for you? 
 
 
0 1 2 3 4 5 6 7 8 9 10 
not at all painful     most severe pain imaginable 
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19. Imagine you are wearing sandals and someone with heavy boots steps on your foot. How 
painful would that be for you? 
 
 
0 1 2 3 4 5 6 7 8 9 10 
not at all painful     most severe pain imaginable 
 
 
20. Imagine you bump your elbow on the edge of a table (‘‘funny bone”). How painful would 
that be for you? 
 
0 1 2 3 4 5 6 7 8 9 10 
not at all painful     most severe pain imaginable 
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Appendix 3: Data Collection Pilot Study 
 
SESSION 1: 
Date: _________________________ 
Time:  _________________________ 
Maximum isometric quadriceps contraction at -10 knee extension 
Test 1  
Test 2  
Test 3  
Average  
40% of average  
 
 
ACTION SET 1 SET 2 SET 3 SET 4 SET 5 
10 reps      
30 sec rest      
10 reps      
30 sec rest      
10 reps      
2 min break      
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SESSION 2: 
Modified Likert Scale of muscle soreness (Andersen et al., 2008) 
Date:  
Time:  
1 A light soreness in the muscle felt only when touched/ a vague 
ache 
2 A moderate soreness felt only when touched/ a slight persistent 
pain 
3 A light muscle soreness while walking up and down stairs 
4 A light muscle soreness when walking on a flat surface 
5 A moderate muscle soreness, stiffness or weakness while walking 
6 A severe muscle soreness, stiffness or weakness that limits my 
ability to move 
 
Does subject fulfil inclusion criteria? __________________ 
Subject number: _________________________________ 
  
  
OUTCOMES: 
(NRS pain score /10) 
 Date: 5 mins 15 mins 25 mins 35 mins 
 Time:        
        
Eccentric Quadriceps contraction NRS –test 1        
 Eccentric Quadriceps contraction NRS- test 2        
Eccentric Quadriceps contraction NRS- test 3     
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Appendix 4: Data Collection Research Study 
 
SESSION 1: 
Date: _________________________ 
Time:  _________________________ 
Maximum isometric quadriceps contraction at -10 knee extension 
Test 1  
Test 2  
Test 3  
Average  
40% of average  
 
Glasses magnification which allows focussed but magnified view of thigh: ___________ 
Position of leg for best focus Leg weights in situ: ________________________________ 
 
ACTION SET 1 SET 2 SET 3 SET 4 SET 5 
10 reps      
30 sec rest      
10 reps      
30 sec rest      
10 reps      
2 min break      
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SESSION 2: 
Modified Likert Scale of muscle soreness (Andersen et al., 2008) 
Date:  
Time:  
1 A light soreness in the muscle felt only when touched/ a vague ache 
2 A moderate soreness felt only when touched/ a slight persistent pain 
3 A light muscle soreness while walking up and down stairs 
4 A light muscle soreness when walking on a flat surface 
5 A moderate muscle soreness, stiffness or weakness while walking 
6 A severe muscle soreness, stiffness or weakness that limits my ability 
to move 
 
 
Does subject fulfil inclusion criteria? __________________ 
Subject number: _________________________________ 
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OUTCOMES: 
(NRS pain score /10) 
 Date: 
test 1 
5 mins 
test 2 
15 mins 
test 3 
25 mins 
test 4  
35 mins 
 Time:        
VISUAL CONDITION - neutral object (X), 
contralateral leg (CL), Normal (N), magnified (M)       
 
Weights strapped around ankle     
5 minute fixation time- subject to made aware that 
they will need to estimate width of thigh after 
fixation testing    
 
        
Eccentric Quadriceps contraction NRS –test 1        
 Eccentric Quadriceps contraction NRS- test 2        
Eccentric Quadriceps contraction NRS- test 3     
     
“Effect of Magnification” Scale- done just prior to 
removal of glasses in magnified condition    
 
Weights removed from ankle prior to washout 
period    
 
5 minute washout period        
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Appendix 5: Letter Granting Ethical Approval 
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Glossary of Abbreviations 
 
ACC anterior cingulate cortex 
AMPA receptors α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
ASQ attribution style questionnaire 
BAQ Body Attitude Questionnaire  
Ca2+ calcium ions  
CGRP Calcitonin Gene Related Peptide 
CREB cAMP response element-binding protein 
CRPS Chronic Regional Pain Syndrome 
DLF dorsolateral fasciculus 
DLPFC dorsolateral prefrontal cortex 
DNIC diffuse noxious inhibitory control system 
DOMS delayed onset muscle soreness 
EEG Electroencephalography 
ERK extracellular signal-related kinase 
ERP Event-related brain potential 
FMRI functional magnetic resonance imaging 
GABA gamma amino-butyric acid 
IASP International Association for the Study of Pain 
IC insular cortex  
ICC inter class correlation co-efficient 
Minification process of reducing something only in appearance, not in physical size 
MEG magnetoencephalography 
Mg2+ magnesium ions  
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NGC nucleus reticularis gigantocellularis 
NMDAR N-methyl-D-aspartate receptor 
NRM nucleus raphe magnus 
NWR nociceptive withdrawal reflex 
PAG periaqueductal grey matter 
PASS-20 pain anxiety symptoms scale questionnaire   
PFC prefrontal cortex  
PKC protein kinase-C  
PPC posterior parietal cortices 
PPI perceived pain intensity 
RVM rostral ventromedial medulla 
S1 somatosensory cortex 
S2 secondary somatosensory cortex 
SCR Skin conductance response 
TENS transcutaneous electrical nerve stimulation 
TRP transient receptor potential 
VAS visual analogue scale 
VPL ventroposteriolateral nucleus 
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